{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:48:10Z","timestamp":1794293290649,"version":"4.9.0"},"reference-count":837,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.anai.2025.10.026","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:23:38Z","timestamp":1775208218000},"page":"426-493.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["2025 Inborn errors of immunity practice parameter"],"prefix":"10.1016","volume":"136","author":[{"given":"Jordan S.","family":"Orange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Chinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Horner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Kobrynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ballow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish J.","family":"Butte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmuganathan","family":"Chandrakasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan K.","family":"Chinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Forbes","family":"Satter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Heimall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica G.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather K.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Risma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolan E.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshini S.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Barmettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara A.","family":"Danziger-Isakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Teresa","family":"De la Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"DiGiacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Dimitriades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morna J.","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Dulek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cullen M.","family":"Dutmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn R.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Frazer-Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avni Y.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin W.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maleewan","family":"Kitcharoensakkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Leiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasiani C.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalakshmi","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yun","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara C.","family":"Pozos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Puck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus S.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.K.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K","family":"Ledford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Mosnaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0001","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1081-1206(10)63442-4","article-title":"Practice parameters for the diagnosis and management of immunodeficiency. The clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI)","volume":"76","author":"Shearer","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0004","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2013.03.034","article-title":"A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema","volume":"131","author":"Zuraw","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0005","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.jaip.2021.09.035","article-title":"Translating evidence to optimize patient care using GRADE","volume":"9","author":"Chu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0006","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2020.07.007","article-title":"Rhinitis 2020: A practice parameter update","volume":"146","author":"Dykewicz","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0007","doi-asserted-by":"crossref","unstructured":"Poli MC, Aksentijevich I, Bousfiha A, Cunningham-Rundles C, Hambleton S, C Klein, et al. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. Accessed November 15, 2024. Available at: https:\/\/iuis.org\/committees\/iei\/","DOI":"10.70962\/jhi.20250003"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0008","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0009","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fimmu.2015.00185","article-title":"Early-onset autoimmune disease as a manifestation of primary immunodeficiency","volume":"6","author":"Carneiro-Sampaio","year":"2015","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0010","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0011","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ACI.0000000000000860","article-title":"Autoimmune and autoinflammatory manifestations in inborn errors of immunity","volume":"22","author":"Ka\u010dar","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1110115","article-title":"Granulomatous inflammation in inborn errors of immunity","volume":"11","author":"Sacco","year":"2023","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0013","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00439-022-02464-7","article-title":"Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice","volume":"142","author":"Azabdaftari","year":"2023","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0014","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MPG.0000000000003017","article-title":"Clinical genomics for the diagnosis of monogenic forms of inflammatory bowel disease: A position paper from the paediatric IBID Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"72","author":"Uhlig","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anai.2025.10.026_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860821","article-title":"Inborn errors of the immune system associated with atopy","volume":"13","author":"Nelson","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0016","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jaip.2022.04.001","article-title":"Atopy as immune dysregulation: offender genes and targets","volume":"10","author":"Vaseghi-Shanjani","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0017","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypical classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J Hum Immun"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0018","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10875-023-01434-6","article-title":"Initial manifestations in Patients with Inborn Errors of Immunity Based on Onset Age: a Study from a Nationwide Survey in Japan","volume":"43","author":"Kido","year":"2023","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0019","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaip.2020.11.044","article-title":"The new \u201cwholly trinity\u201d in the diagnosis and management of inborn errors of immunity","volume":"9","author":"Abraham","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MOP.0000000000001178","article-title":"Navigating diagnostic options for inborn errors of immunity in children: a case-based illustration","volume":"34","author":"Khan","year":"2022","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0021","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jaip.2023.03.049","article-title":"Inborn errors of immunity: A role for functional testing and flow cytometry in aiding clinical diagnosis","volume":"11","author":"Ma","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.10.026_bib0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fimmu.2019.00033","article-title":"The expanding field of secondary antibody deficiency: causes, diagnosis, and management","volume":"10","author":"Patel","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0023","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.anai.2021.08.413","article-title":"Secondary immunodeficiencies: an overview","volume":"127","author":"Tuano","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0024","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028241","article-title":"Cilia and mucociliary clearance","volume":"9","author":"Bustamante-Marin","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/jclinpath-2019-206235","article-title":"Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID)","volume":"73","author":"Ponsford","year":"2020","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0026","first-page":"560","article-title":"Cunninham-Rundles C. Oxcarbazepine-induced immunoglobulin deficiency","volume":"12","author":"Knight","year":"2005","journal-title":"Clin Digan Lab Immunol"},{"issue":"24","key":"10.1016\/j.anai.2025.10.026_bib0027","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1111\/febs.15770","article-title":"Hallmarks of the aging T-cell system","volume":"288","author":"Zhang","year":"2021","journal-title":"FEBS J"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0028","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/cells11030359","article-title":"Interconnections between inflammageing and immunosenescence during ageing","volume":"11","author":"Teissier","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.anai.2025.10.026_bib0029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fped.2017.00023","article-title":"Age-appropriate functions and dysfunctions of the neonatal neutrophil","volume":"5","author":"Lawrence","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.anai.2025.10.026_bib0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-immunol-091319-083608","article-title":"Neonatal T cells: A reinterpretation","volume":"38","author":"Rudd","year":"2020","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0031","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1542\/peds.104.6.1327","article-title":"Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal\/permeability-increasing protein","volume":"104","author":"Levy","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2025.10.026_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113313","article-title":"Anti-cytokine autoantibodies and inborn errors of immunity","volume":"508","author":"Sadighi Akha","year":"2022","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0033","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jalm\/jfab139","article-title":"Immunodeficiency and autoantibodies to cytokines","volume":"7","author":"Knight","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41577-023-00933-2","article-title":"Anti-cytokine autoantibodies: mechanistic insights and disease associations","volume":"24","author":"Cheng","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"10.1016\/j.anai.2025.10.026_bib0035","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1182\/blood-2010-05-286161","article-title":"Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia","volume":"116","author":"Burbelo","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0036","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1185\/03007995.2014.1001063","article-title":"Diagnosing primary immunodeficiency: a practical approach for the non-immunologist","volume":"31","author":"Lehman","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0037","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/pch\/21.2.e10","article-title":"Primary immunodeficiency for the primary care provider","volume":"21","author":"O'Keefe","year":"2016","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.anai.2025.10.026_bib0038","first-page":"12","article-title":"Family physician perspectives on primary immunodeficiency diseases","volume":"3","author":"Orange","year":"2016","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0039","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10875-014-0003-x","article-title":"ICON: the early diagnosis of congenital immunodeficiencies","volume":"34","author":"Routes","year":"2014","journal-title":"J Clin Immunol"},{"issue":"9653","key":"10.1016\/j.anai.2025.10.026_bib0040","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(08)61802-4","article-title":"Primary immunodeficiency: a call for multidisciplinary care","volume":"372","author":"Stirling","year":"2008","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.anai.2025.10.026_bib0041","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/hae.13010","article-title":"Integrated multidisciplinary care for the management of chronic conditions in adults: an overview of reviews and an example of using indirect evidence to inform clinical practice recommendations in the field of rare diseases","volume":"22","author":"Yeung","year":"2016","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0042","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-022-02309-6","article-title":"Designing rare disease care pathways in the Republic of Ireland: a co-operative model","volume":"17","author":"Ward","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0043","first-page":"169","article-title":"Integrated multidisciplinary treatment for pediatric inflammatory bowel disease","volume":"8","author":"Wren","year":"2021","journal-title":"Children (Basel)"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0044","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/genes13111949","article-title":"The unique experience of a new multidisciplinary program for 22q deletion and duplication syndromes in a community hospital in Florida: a reaffirmation that multidisciplinary care is essential for best outcomes in these patients","volume":"13","author":"Meneses","year":"2022","journal-title":"Genes (Basel)"},{"issue":"23","key":"10.1016\/j.anai.2025.10.026_bib0045","article-title":"Disparities in diagnosis, access to specialist care and treatment for inborn errors of immunity","volume":"S2213-2198","author":"Lawrence","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0046","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/1750743X.2024.2367924","article-title":"A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents","volume":"16","author":"Fasshauer","year":"2024","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0047","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2500\/aap.2016.37.3977","article-title":"Anxiety and depression in adults with primary immunodeficiency: how much do these patients experience and how much do they attribute to their primary immunodeficiency?","volume":"37","author":"Heath","year":"2016","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0048","doi-asserted-by":"crossref","first-page":"e14068","DOI":"10.1111\/pai.14068","article-title":"Life quality, depression, and anxiety levels in parents of children with primary immunodeficiency","volume":"35","author":"Kaplan Sar\u0131kavak","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0049","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10875-020-00886-4","article-title":"Parents\u2019 perspectives and societal acceptance of implementation of newborn screening for SCID in the Netherlands","volume":"41","author":"Blom","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0050","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3389\/fimmu.2020.00885","article-title":"Information and emotional support needs of families whose infant was diagnosed with SCID through newborn screening","volume":"11","author":"Raspa","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0051","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41431-023-01345-5","article-title":"Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening","volume":"32","author":"Raspa","year":"2024","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0052","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.01.032","article-title":"Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles","volume":"129","author":"Puck","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0053","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2011.12.004","article-title":"The Wisconsin approach to newborn screening for severe combined immunodeficiency","volume":"129","author":"Verbsky","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0054","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ymgme.2011.07.007","article-title":"A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID)","volume":"104","author":"Chan","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0055","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jpeds.2005.06.001","article-title":"Potential costs and benefits of newborn screening for severe combined immunodeficiency","volume":"147","author":"McGhee","year":"2005","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0056","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaip.2014.05.013","article-title":"Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency","volume":"2","author":"Kubiak","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0057","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10875-011-9598-3","article-title":"Expert commentary: practical issues in newborn screening for severe combined immune deficiency (SCID)","volume":"32","author":"Puck","year":"2012","journal-title":"J Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0058","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States","volume":"312","author":"Kwan","year":"2014","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.anai.2025.10.026_bib0059","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study","volume":"130","author":"Heimall","year":"2017","journal-title":"Blood"},{"issue":"10396","key":"10.1016\/j.anai.2025.10.026_bib0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(23)00731-6","article-title":"Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium","volume":"402","author":"Thakar","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0061","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jaci.2021.08.026","article-title":"Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency","volume":"149","author":"Blom","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0062","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13023-016-0557-1","article-title":"FOXN1 deficient nude severe combined immunodeficiency","volume":"12","author":"Rota","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0063","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10875-021-01059-7","article-title":"Congenital athymia: genetic etiologies, clinical manifestations, diagnosis, and treatment","volume":"41","author":"Collins","year":"2021","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0064","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s10875-012-9846-1","article-title":"Newborn screening for SCID identifies patients with ataxia telangiectasia","volume":"33","author":"Mallott","year":"2013","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s10875-017-0403-9","article-title":"Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency","volume":"37","author":"Barry","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108932","article-title":"Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II","volume":"235","author":"Damoiseaux","year":"2022","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0067","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-005579","article-title":"Delayed-onset ADA1 (ADA) deficiency not detected by TREC screen","volume":"147","author":"Kahwash","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2025.10.026_bib0068","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpba.2013.08.044","article-title":"The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry","volume":"88","author":"la Marca","year":"2014","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0069","doi-asserted-by":"crossref","first-page":"e15872","DOI":"10.1111\/ped.15872","article-title":"A high-throughput TREC- and KREC-based newborn screening for severe inborn errors of immunity","volume":"67","author":"Hiroki","year":"2025","journal-title":"Pediatr Int"},{"key":"10.1016\/j.anai.2025.10.026_bib0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1749-6632.2011.06350.x","article-title":"Newborn screening for primary immunodeficiencies: beyond SCID and XLA","volume":"1246","author":"Borte","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0071","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ijns9020022","article-title":"Genomic-based newborn screening for inborn errors of immunity: practical and ethical considerations","volume":"9","author":"King","year":"2023","journal-title":"Int J Neonatal Screen"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0072","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.ajhg.2022.08.003","article-title":"A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases","volume":"109","author":"Kingsmore","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0073","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2300","article-title":"Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010-2017","volume":"143","author":"Amatuni","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0074","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/ijns6030052","article-title":"Follow-up for an abnormal newborn screen for severe combined immunodeficiencies (NBS SCID): a clinical immunology society (CIS) survey of current practices","volume":"6","author":"Knight","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0075","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/14737159.2023.2244879","article-title":"Efficient screening strategies for severe combined immunodeficiencies in newborns","volume":"23","author":"Blom","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0076","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaci.2022.10.022","article-title":"The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions","volume":"151","author":"Dvorak","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0077","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10875-020-00865-9","article-title":"Infections in infants with SCID: isolation, infection screening, and prophylaxis in PIDTC centers","volume":"41","author":"Dorsey","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109182","article-title":"Natural history of infants with non-SCID T cell lymphopenia identified on newborn screen","volume":"245","author":"Kubala","year":"2022","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0079","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41390-020-0886-6","article-title":"Primary immunodeficiency testing in a Massachusetts tertiary care NICU: persistent challenges in the extremely premature population","volume":"89","author":"Frazer","year":"2021","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12026-022-09297-6","article-title":"In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management","volume":"70","author":"Carol","year":"2022","journal-title":"Immunol Res"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0081","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.2022016196","article-title":"Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC","volume":"140","author":"Cuvelier","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0082","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0083","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2021.06.028","article-title":"Experience with cultured thymus tissue in 105 children","volume":"149","author":"Markert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0084","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.804709","article-title":"Severe combined immunodeficiency: knowledge and information needs among healthcare providers","volume":"10","author":"Kutsa","year":"2022","journal-title":"Front Pediatr"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0085","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10875-019-00671-y","article-title":"Survey of infection control precautions for patients with severe combined immune deficiency","volume":"39","author":"Dergousoff","year":"2019","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0086","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3390\/v13101897","article-title":"Clinical, virologic and immunologic correlates of breast milk acquired cytomegalovirus (CMV) infections in very low birth weight (VLBW) infants in a Newborn Intensive Care Unit (NICU) setting","volume":"13","author":"Hernandez-Alvarado","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0087","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2013.11.043","article-title":"Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"40","key":"10.1016\/j.anai.2025.10.026_bib0088","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1016\/j.vaccine.2010.07.039","article-title":"Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS)","volume":"28","author":"Bakare","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0089","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10875-020-00956-7","article-title":"Newborn screening for severe combined immunodeficiency: 10-year experience at a single referral center (2009-2018)","volume":"41","author":"Thorsen","year":"2021","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2016.05.042","article-title":"Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders","volume":"139","author":"Stray-Pedersen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0091","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0092","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1373\/clinchem.2015.249623","article-title":"Systematic evaluation of sanger validation of next-generation sequencing variants","volume":"62","author":"Beck","year":"2016","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0093","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/gim.2013.183","article-title":"Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory","volume":"16","author":"Strom","year":"2014","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0094","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jmoldx.2015.03.004","article-title":"Confirming variants in next-generation sequencing panel testing by sanger sequencing","volume":"17","author":"Baudhuin","year":"2015","journal-title":"J Mol Diagn"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00438-021-01772-3","article-title":"Performance comparison: exome sequencing as a single test replacing Sanger sequencing","volume":"296","author":"Fridman","year":"2021","journal-title":"Mol Genet Genomics"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0096","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1038\/s41598-021-85182-w","article-title":"Sanger sequencing is no longer always necessary based on a single-center validation of 1109 NGS variants in 825 clinical exomes","volume":"11","author":"Arteche-L\u00f3pez","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0097","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/gim.2016.58","article-title":"Navigating highly homologous genes in a molecular diagnostic setting: a resource for clinical next-generation sequencing","volume":"18","author":"Mandelker","year":"2016","journal-title":"Genet Med"},{"issue":"25","key":"10.1016\/j.anai.2025.10.026_bib0098","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2010-01-263145","article-title":"Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome","volume":"115","author":"Dowdell","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0099","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/art.30512","article-title":"High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study","volume":"63","author":"Tanaka","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0100","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.20980","article-title":"Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques","volume":"30","author":"Rohlin","year":"2009","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0101","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s10875-021-01037-z","article-title":"Genetic mosaicism as a cause of inborn errors of immunity","volume":"41","author":"Aluri","year":"2021","journal-title":"J Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0102","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/1744666X.2020.1814145","article-title":"A 2020 update on the use of genetic testing for patients with primary immunodeficiency","volume":"16","author":"Chinn","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0103","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10875-018-0489-8","article-title":"Use of genetic testing for primary immunodeficiency patients","volume":"38","author":"Heimall","year":"2018","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0104","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2019.09.009","article-title":"Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: a working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology","volume":"145","author":"Chinn","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0105","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1101\/gr.092981.109","article-title":"Sensitive and accurate detection of copy number variants using read depth of coverage","volume":"19","author":"Yoon","year":"2009","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0106","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12920-021-01059-x","article-title":"Detecting copy number variation in next generation sequencing data from diagnostic gene panels","volume":"14","author":"Singh","year":"2021","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0107","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41431-020-0672-2","article-title":"Detection of copy-number variations from NGS data using read depth information: a diagnostic performance evaluation","volume":"29","author":"Quenez","year":"2021","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0108","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaci.2020.08.022","article-title":"Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency","volume":"147","author":"Platt","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0109","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3389\/fimmu.2019.02325","article-title":"Expanding the clinical and genetic spectra of primary immunodeficiency-related disorders with clinical exome sequencing: expected and unexpected findings","volume":"10","author":"Rudilla","year":"2019","journal-title":"Front Immunol"},{"issue":"7814","key":"10.1016\/j.anai.2025.10.026_bib0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41586-020-2265-1","article-title":"Whole-genome sequencing of a sporadic primary immunodeficiency cohort","volume":"583","author":"Thaventhiran","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0111","doi-asserted-by":"crossref","first-page":"16719","DOI":"10.1038\/s41598-018-34953-z","article-title":"Somatic alterations compromised molecular diagnosis of DOCK8 hyper-IgE syndrome caused by a novel intronic splice site mutation","volume":"8","author":"Hagl","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0112","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41525-022-00295-z","article-title":"Best practices for the interpretation and reporting of clinical whole genome sequencing","volume":"7","author":"Austin-Tse","year":"2022","journal-title":"NPJ Genom Med"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0113","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41431-022-01162-2","article-title":"Whole exome and genome sequencing in Mendelian disorders: a diagnostic and health economic analysis","volume":"30","author":"Ewans","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0114","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12016-021-08838-5","article-title":"Next-generation sequencing in the field of primary immunodeficiencies: current yield, challenges, and future perspectives","volume":"61","author":"Vorsteveld","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0115","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10875-022-01276-8","article-title":"Copy number analysis in a large cohort suggestive of inborn errors of immunity indicates a wide spectrum of relevant chromosomal losses and gains","volume":"42","author":"Wan","year":"2022","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0116","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaci.2022.06.009","article-title":"Clinical exome sequencing of 1000 families with complex immune phenotypes: toward comprehensive genomic evaluations","volume":"150","author":"Similuk","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"7118","key":"10.1016\/j.anai.2025.10.026_bib0117","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05329","article-title":"Global variation in copy number in the human genome","volume":"444","author":"Redon","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0118","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.909","article-title":"A copy number variation morbidity map of developmental delay","volume":"43","author":"Cooper","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.anai.2025.10.026_bib0119","article-title":"Traditional banding of chromosomes for cytogenetic analysis","author":"Bayani","year":"2004","journal-title":"Curr Protoc Cell Biol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0120","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/GIM.0b013e31822272ac","article-title":"American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities","volume":"13","author":"Kearney","year":"2011","journal-title":"Genet Med"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209185","article-title":"Increasing the diagnostic yield of exome sequencing by copy number variant analysis","volume":"13","author":"Marchuk","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0122","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/gim.2014.160","article-title":"Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort","volume":"17","author":"Retterer","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0123","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","article-title":"Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)","volume":"22","author":"Riggs","year":"2020","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0124","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","article-title":"Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies","volume":"86","author":"Miller","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0126","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1002\/cphg.93","article-title":"Overview of specifications to the ACMG\/AMP variant interpretation guidelines","volume":"103","author":"Harrison","year":"2019","journal-title":"Curr Protoc Hum Genet"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0127","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1182\/bloodadvances.2020003712","article-title":"Specifications of the variant curation guidelines for ITGA2B\/ITGB3: ClinGen Platelet Disorder Variant Curation Panel","volume":"5","author":"Ross","year":"2021","journal-title":"Blood Adv"},{"issue":"23","key":"10.1016\/j.anai.2025.10.026_bib0128","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen\u2013the clinical genome resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2025.10.026_bib0129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-genom-121620-082709","article-title":"The science and art of clinical genetic variant classification and its impact on test accuracy","volume":"22","author":"Giles","year":"2021","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM197507312930513","article-title":"Letter: Nomogram for Bayes's theorem","volume":"293","author":"Fagan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2025.10.026_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109896","article-title":"Clinical heterogeneity in families with multiple cases of inborn errors of immunity","volume":"259","author":"Delavari","year":"2024","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0132","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/blood-2003-06-1964","article-title":"Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation","volume":"103","author":"Takada","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0133","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<367::AID-IMMU367>3.0.CO;2-4","article-title":"CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization","volume":"29","author":"de Saint Basile","year":"1999","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0134","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clim.2003.08.002","article-title":"Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation","volume":"109","author":"Anderson-Cohen","year":"2003","journal-title":"Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0135","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s10875-023-01564-x","article-title":"An atypical incontinentia pigmenti female with persistent mucocutaneous hyperinflammation and immunodeficiency caused by a novel germline IKBKG missense mutation","volume":"43","author":"Mou","year":"2023","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0136","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2141.1995.tb03403.x","article-title":"Random X chromosome inactivation in a female with a variant of Wiskott-Aldrich syndrome","volume":"90","author":"Russell","year":"1995","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0137","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.jaip.2024.09.018","article-title":"Severe clinical phenotypes of heterozygous females with X-linked chronic granulomatous disease","volume":"12","author":"Patel","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.10.026_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110364","article-title":"High symptom burden in female X-linked chronic granulomatous disease carriers","volume":"268","author":"Miranda","year":"2024","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0139","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"8048","key":"10.1016\/j.anai.2025.10.026_bib0140","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41586-024-08346-4","article-title":"Monoallelic expression can govern penetrance of inborn errors of immunity","volume":"637","author":"Stewart","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.anai.2025.10.026_bib0141","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2024.117303","article-title":"Renegotiation, uncertainty, imagination: assemblage perspectives on reproductive and family planning with an Inborn Error of immunity","volume":"360","author":"Davidson","year":"2024","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0142","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1516767","article-title":"Resolution of disease phenotypes resulting from multilocus genomic variation","volume":"376","author":"Posey","year":"2017","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.anai.2025.10.026_bib0143","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2014.14601","article-title":"Molecular findings among patients referred for clinical whole-exome sequencing","volume":"312","author":"Yang","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0144","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2021.03.005","article-title":"State-of-the-art diagnostic evaluation of common variable immunodeficiency","volume":"127","author":"Lee","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0146","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"17","key":"10.1016\/j.anai.2025.10.026_bib0147","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3390\/diagnostics13172861","article-title":"Selective IgM deficiency: evidence, controversies, and gaps","volume":"13","author":"Taietti","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0148","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.anai.2024.04.025","article-title":"IgE deficiency is not associated with hypogammaglobulinemia in a large cohort of military recruits","volume":"133","author":"Makin","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0149","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jaci.2022.01.025","article-title":"Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees","volume":"149","author":"Otani","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/gastro\/gou082","article-title":"Frequency and risk factors of low immunoglobulin levels in patients with inflammatory bowel disease","volume":"3","author":"Rai","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0151","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jaip.2022.03.017","article-title":"Response to severe acute respiratory syndrome coronavirus 2 initial series and additional dose vaccine in patients with predominant antibody deficiency","volume":"10","author":"Barmettler","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0152","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0153","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.anai.2025.10.026_bib0154","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3389\/fimmu.2017.01740","article-title":"Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets","volume":"8","author":"Farmer","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0156","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2249.2012.04643.x","article-title":"T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections","volume":"170","author":"Bateman","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0157","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clim.2009.03.519","article-title":"Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with common variable immunodeficiency: a link to autoimmunity?","volume":"132","author":"Genre","year":"2009","journal-title":"Clin Immunol"},{"issue":"6204","key":"10.1016\/j.anai.2025.10.026_bib0158","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0159","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(19)30417-7","article-title":"Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial","volume":"20","author":"Raven","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"3 Suppl","key":"10.1016\/j.anai.2025.10.026_bib0161","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0162","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pathol.2019.12.008","article-title":"Anti-pneumococcal antibody measurement: implications of discordance between second and third generation assays","volume":"52","author":"Allan","year":"2020","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0163","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Med (Baltim)"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0164","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s10875-023-01502-x","article-title":"A registry study of 240 patients with X-linked agammaglobulinemia living in the USA","volume":"43","author":"Hernandez-Trujillo","year":"2023","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0165","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10875-022-01237-1","article-title":"X-linked agammaglobulinemia: infection frequency and infection-related mortality in the USIDNET Registry","volume":"42","author":"O'Toole","year":"2022","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0166","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s12185-009-0322-5","article-title":"Pneumocystis jiroveci pneumonia as an atypical presentation of X-linked agammaglobulinemia","volume":"89","author":"Kanegane","year":"2009","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0167","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2003.11.011","article-title":"Search for poliovirus long-term excretors among patients affected by agammaglobulinemia","volume":"111","author":"Fiore","year":"2004","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0168","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4103\/0028-3886.82768","article-title":"Recurrent pyogenic meningitis in a 17-year-old: a delayed presentation of X-linked agammaglobulinemia with growth hormone deficiency","volume":"59","author":"Sabnis","year":"2011","journal-title":"Neurol India"},{"key":"10.1016\/j.anai.2025.10.026_bib0169","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0105-2896.2005.00233.x","article-title":"Genetic analysis of patients with defects in early B-cell development","volume":"203","author":"Conley","year":"2005","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.gene.6364391","article-title":"Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia","volume":"8","author":"Ferrari","year":"2007","journal-title":"Genes Immun"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0171","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/ACI.0b013e328314b621","article-title":"Ig beta deficiency in humans","volume":"8","author":"Lougaris","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0172","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.20112533","article-title":"Agammaglobulinemia and absent B lineage cells in a patient lacking the p85\u03b1 subunit of PI3K","volume":"209","author":"Conley","year":"2012","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0173","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1172\/JCI71927","article-title":"A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells","volume":"123","author":"Boisson","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0174","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/s41467-019-11570-6","article-title":"Mutations in topoisomerase II\u03b2 result in a B cell immunodeficiency","volume":"10","author":"Broderick","year":"2019","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0175","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201750","article-title":"Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients","volume":"218","author":"Le Coz","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.anai.2025.10.026_bib0176","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8416124","article-title":"Global distribution of common variable immunodeficiency (CVID) in the light of the UNDP Human Development Index (HDI): a preliminary perspective of a rare disease","volume":"2020","author":"Weifenbach","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.anai.2025.10.026_bib0177","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3389\/fimmu.2017.01190","article-title":"Unexpectedly high prevalence of common variable immunodeficiency in Finland","volume":"8","author":"Selenius","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0178","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.815710","article-title":"Good's Syndrome: time to move on from reviewing the past","volume":"12","author":"Kabir","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0179","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/BOR.0b013e3282fd6e70","article-title":"Osteoarticular infectious complications in patients with primary immunodeficiencies","volume":"20","author":"Bloom","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaip.2017.05.024","article-title":"Respiratory infections and antibiotic usage in common variable immunodeficiency","volume":"6","author":"Sperlich","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.10.026_bib0181","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1209570","article-title":"Characterization of infectious and non-infectious gastrointestinal disease in common variable immunodeficiency: analysis of 114 patient cohort","volume":"14","author":"Sanchez","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0182","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3389\/fimmu.2019.02753","article-title":"Current understanding and recent developments in common variable immunodeficiency associated autoimmunity","volume":"10","author":"Gereige","year":"2019","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0183","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anai.2025.10.026_bib0184","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1197361","article-title":"Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease","volume":"14","author":"Daza-Cajigal","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864550","article-title":"Liver stiffness by transient elastography correlates with degree of portal hypertension in common variable immunodeficiency patients with nodular regenerative hyperplasia","volume":"13","author":"DiGiacomo","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0186","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.iac.2020.03.003","article-title":"Chronic lung disease in primary antibody deficiency: diagnosis and management","volume":"40","author":"Maglione","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.anai.2025.10.026_bib0187","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190235","article-title":"Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review","volume":"14","author":"Bintalib","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0188","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-016-0597-6","article-title":"Autoimmune and lymphoproliferative complications of common variable immunodeficiency","volume":"16","author":"Maglione","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0189","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jaip.2023.01.048","article-title":"The Rapidly Expanding Genetic Spectrum of Common Variable Immunodeficiency-Like Disorders","volume":"11","author":"Ameratunga","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0190","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1182\/blood.2019000929","article-title":"Cunningham-Rundles C. Current genetic landscape in common variable immune deficiency","volume":"135","author":"Abolhassani","year":"2020","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0191","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","article-title":"CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency","volume":"128","author":"Lo","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0192","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cei.13600","article-title":"Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review","volume":"205","author":"Jamee","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0193","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaip.2023.09.016","article-title":"PI3K\u03b4 pathway dysregulation and unique features of its inhibition by leniolisib in activated PI3K\u03b4 syndrome and beyond","volume":"12","author":"Cant","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0194","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/sji.12499","article-title":"Selective IgA deficiency: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management","volume":"85","author":"Yazdani","year":"2017","journal-title":"Scand J Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0195","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-3148.2011.01082.x","article-title":"Prevalence of immunoglobulin A deficiency in Chinese blood donors and evaluation of anaphylactic transfusion reaction risk","volume":"21","author":"Feng","year":"2011","journal-title":"Transfus Med"},{"issue":"3 Pt 1","key":"10.1016\/j.anai.2025.10.026_bib0196","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/clin.1996.0132","article-title":"Development of a common variable immunodeficiency in IgA-deficient patients","volume":"80","author":"Espa\u00f1ol","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0197","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000135694","article-title":"Progression of selective IgA deficiency to common variable immunodeficiency","volume":"147","author":"Aghamohammadi","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0198","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/1744666X.2016.1198696","article-title":"Monogenic mutations associated with IgA deficiency","volume":"12","author":"Abolhassani","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0199","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s10875-019-00647-y","article-title":"Clinical and laboratory features of 184 Italian pediatric patients affected with selective IgA deficiency (SIgAD): a longitudinal single-center study","volume":"39","author":"Lougaris","year":"2019","journal-title":"J Clini Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MPG.0000000000002634","article-title":"Influence of the 2012 European guidelines in diagnosis and follow up of coeliac children with selective IgA deficiency","volume":"71","author":"L\u00f3pez","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0201","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM198509193131203","article-title":"Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3","volume":"313","author":"Bj\u00f6rkander","year":"1985","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0203","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10875-016-0236-y","article-title":"The challenge of immunoglobulin G subclass deficiency and specific polysaccharide antibody deficiency- a Dutch pediatric cohort study","volume":"36","author":"Schatone","year":"2016","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0204","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1203\/00006450-199001000-00004","article-title":"Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2","volume":"27","author":"Shackelford","year":"1990","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10875-019-00691-8","article-title":"Defining polysaccharide antibody deficiency: measurement of anti-pneumococcal antibodies and anti-salmonella typhi antibodies in a cohort of patients with recurrent infections","volume":"40","author":"Bucciol","year":"2020","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0206","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.anai.2022.05.028","article-title":"Specific antibody deficiency: pearls and pitfalls for diagnosis","volume":"129","author":"Lawrence","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"23","key":"10.1016\/j.anai.2025.10.026_bib0207","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1016\/j.vaccine.2022.04.042","article-title":"Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders","volume":"40","author":"Beulens","year":"2022","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0208","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","article-title":"Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)","volume":"102","author":"Revy","year":"2000","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0209","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/clim.2000.4956","article-title":"Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome","volume":"97","author":"Minegishi","year":"2000","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","article-title":"Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced cytidine deaminase deficiency","volume":"110","author":"Quartier","year":"2004","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0211","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jaci.2006.01.043","article-title":"Defects of class-switch recombination","volume":"117","author":"Notarangelo","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0212","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/08916934.2012.750299","article-title":"Potential roles of activation induced cytidine deaminase in promotion or prevention of autoimmunity in humans","volume":"46","author":"Durandy","year":"2013","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0213","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0214","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/039463200802100211","article-title":"A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network","volume":"21","author":"Moschese","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0215","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1399-3038.2010.01010.x","article-title":"Transient hypogammaglobulinemia and unclassified hypogammaglobulinemia: \u2018similarities and differences","volume":"21","author":"Keles","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0216","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clim.2010.08.010","article-title":"Outcome of hypogammaglobulinemia in children: immunoglobulin levels as predictors","volume":"137","author":"Ozen","year":"2010","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0217","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/039463201102400318","article-title":"Evolution of hypogammaglobulinemia in premature and full-term infants","volume":"24","author":"Ricci","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0218","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jaci.2024.08.002","article-title":"Variants in IGLL1 cause a broad phenotype from agammaglobulinemia to transient hypogammaglobulinemia","volume":"154","author":"Soomann","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0219","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1203\/PDR.0b013e3181a7b0a2","article-title":"The B-cell compartment in the peripheral blood of children with different types of primary humoral immunodeficiency","volume":"66","author":"Bukowska-Strakov\u00e1","year":"2009","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10238-012-0200-y","article-title":"Reduced CD19 expression and decreased memory B cell numbers in transient hypogammaglobulinemia of infancy","volume":"13","author":"Artac","year":"2013","journal-title":"Clin Exp Med"},{"issue":"1821","key":"10.1016\/j.anai.2025.10.026_bib0221","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"issue":"1 Pt 1","key":"10.1016\/j.anai.2025.10.026_bib0222","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome","volume":"131","author":"Levy","year":"1997","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0223","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/peds.13.2.133","article-title":"Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea","volume":"13","author":"Aldrich","year":"1954","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2025.10.026_bib0224","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4933-7-4","article-title":"The effect of ageing on human lymphocyte subsets: comparison of males and females","volume":"7","author":"Yan","year":"2010","journal-title":"Immun Ageing"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cellimm.2011.10.009","article-title":"Gender effect on in vitro lymphocyte subset levels of healthy individuals","volume":"272","author":"Abdullah","year":"2012","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0226","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131487","article-title":"Perfect timing: circadian rhythms, sleep, and immunity - an NIH workshop summary","volume":"5","author":"Haspel","year":"2020","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0227","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3324\/haematol.2010.030395","article-title":"Autoimmune lymphoproliferative syndrome: a multifactorial disorder","volume":"95","author":"Rieux-Laucat","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0228","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199001113220201","article-title":"Relative increase of T cells expressing the gamma\/delta rather than the alpha\/beta receptor in Ataxia-telangiectasia","volume":"322","author":"Carbonari","year":"1990","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0229","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/qjmed\/hci112","article-title":"Clinical and immunological aspects of HLA class I deficiency","volume":"98","author":"Zimmer","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.anai.2025.10.026_bib0230","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3389\/fimmu.2020.00831","article-title":"Clinical, immunological, and genetic features in 49 patients with ZAP-70 deficiency: A systematic review","volume":"11","author":"Sharifinejad","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0231","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fimmu.2018.00188","article-title":"Clinical, immunological, and molecular findings in five patients with major histocompatibility complex Class II deficiency from India","volume":"9","author":"Aluri","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0232","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10875-015-0186-9","article-title":"Nijmegen breakage syndrome: clinical and immunological features, long-term outcome and treatment options - a retrospective analysis","volume":"35","author":"Wolska-Ku\u015bnierz","year":"2015","journal-title":"J Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0233","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI18714","article-title":"A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency","volume":"112","author":"Courtois","year":"2003","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0234","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1084\/jem.20180639","article-title":"Gain-of-function IKBKB mutation causes human combined immune deficiency","volume":"215","author":"Cardinez","year":"2018","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0235","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2249.2010.04152.x","article-title":"Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles","volume":"161","author":"Lima","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0236","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113327","article-title":"Flow cytometry for B-cell subset analysis in immunodeficiencies","volume":"509","author":"Kum\u00e1novics","year":"2022","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.anai.2025.10.026_bib0237","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108638","article-title":"Class Switch Recombination Defects: impact on B cell maturation and antibody responses","volume":"222","author":"Renner","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0238","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"issue":"19","key":"10.1016\/j.anai.2025.10.026_bib0239","doi-asserted-by":"crossref","first-page":"e94275","DOI":"10.1172\/jci.insight.94275","article-title":"DOCK8 regulates fitness and function of regulatory T cells through modulation of IL-2 signaling","volume":"2","author":"Singh","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/649840","article-title":"CD4(+)CD25(+\/hi)CD127(lo) phenotype does not accurately identify regulatory T cells in all populations of HIV-infected persons","volume":"201","author":"Del Pozo-Balado Mdel","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0241","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0242","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0243","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.coi.2021.06.011","article-title":"Molecular regulation and dysregulation of T follicular helper cells - learning from inborn errors of immunity","volume":"72","author":"Tangye","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0244","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41577-022-00693-5","article-title":"The link between circulating follicular helper T cells and autoimmunity","volume":"22","author":"Walker","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0245","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood.2021012924","article-title":"T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome","volume":"139","author":"Kumar","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.anai.2025.10.026_bib0246","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2012.00234","article-title":"The STAT5b pathway defect and autoimmunity","volume":"3","author":"Kanai","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0247","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.2011.06295.x","article-title":"DOCK8 deficiency","volume":"1246","author":"Su","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.anai.2025.10.026_bib0248","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2018.00446","article-title":"Exhaustion of the CD8+ T cell compartment in patients with mutations in phosphoinositide 3-kinase Delta","volume":"9","author":"Wentink","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0249","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0250","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.674572","article-title":"Wiskott-Aldrich syndrome protein: roles in signal transduction in T cells","volume":"9","author":"Ngoenkam","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0251","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bj.2022.01.013","article-title":"Inherited immunodeficiencies associated with proximal and distal defects in T cell receptor signaling and co-signaling","volume":"45","author":"Latour","year":"2022","journal-title":"Biomed J"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0252","first-page":"1857","article-title":"Measuring lymphocyte proliferation in response to specific antigen and mitogen stimuli using flow cytometry","volume":"62","author":"Heider","year":"2016","journal-title":"Clin Lab"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0253","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.2022017667","article-title":"Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT","volume":"141","author":"Schuetz","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0254","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/JLB.5MA0220-239R","article-title":"Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene","volume":"108","author":"Cifaldi","year":"2020","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0255","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clim.2013.08.006","article-title":"The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation","volume":"149","author":"Lee","year":"2013","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0256","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1203\/01.PDR.0000139318.65842.4A","article-title":"The hyper IgM syndrome\u2013an evolving story","volume":"56","author":"Etzioni","year":"2004","journal-title":"Pediatr Res"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0257","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00431-011-1400-2","article-title":"Study of patients with Hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature","volume":"170","author":"Karaca","year":"2011","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0258","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10875-022-01255-z","article-title":"Atypical autosomal recessive aid deficiency-yet another piece of the hyper-IGM puzzle","volume":"42","author":"Della Mina","year":"2022","journal-title":"J Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0259","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1084\/jem.20050042","article-title":"B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil","volume":"201","author":"Kavli","year":"2005","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0260","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1172\/JCI21345","article-title":"Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation","volume":"114","author":"Jain","year":"2004","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0261","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12185-017-2263-8","article-title":"Recent advances in the study of immunodeficiency and DNA damage response","volume":"106","author":"Morio","year":"2017","journal-title":"Int J Hematol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0262","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2174\/1871530319666190225114739","article-title":"PIK3R1 mutation associated with hyper IgM (APDS2 syndrome): A case report and review of the literature","volume":"19","author":"Yazdani","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0263","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaci.2014.06.001","article-title":"MHC class I and II deficiencies","volume":"134","author":"Hanna","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0264","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood.V55.2.243.243","article-title":"The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets","volume":"55","author":"Ochs","year":"1980","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0265","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00130832-200312000-00003","article-title":"WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype","volume":"3","author":"Imai","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0266","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1182\/blood.V86.10.3797.bloodjournal86103797","article-title":"The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene","volume":"86","author":"Zhu","year":"1995","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0267","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ng0495-414","article-title":"X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene","volume":"9","author":"Villa","year":"1995","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0268","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1182\/blood-2006-01-010249","article-title":"Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia","volume":"108","author":"Ancliff","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0269","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/85886","article-title":"Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia","volume":"27","author":"Devriendt","year":"2001","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0270","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI44862","article-title":"IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function","volume":"121","author":"Orange","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0271","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaci.2018.04.017","article-title":"Screening for Wiskott-Aldrich syndrome by flow cytometry","volume":"142","author":"Chiang","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"25","key":"10.1016\/j.anai.2025.10.026_bib0272","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJM199806183382515","article-title":"X-linked Wiskott-Aldrich syndrome in a girl","volume":"338","author":"Cazzola","year":"1998","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0273","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s10875-013-9927-9","article-title":"Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia","volume":"33","author":"Boonyawat","year":"2013","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0274","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bcmd.2013.04.004","article-title":"X-linked thrombocytopenia in a female with a complex familial pattern of X-chromosome inactivation","volume":"51","author":"Daza-Cajigal","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.anai.2025.10.026_bib0275","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.3389\/fimmu.2018.02554","article-title":"The phenotype and treatment of WIP deficiency: literature synopsis and review of a patient with pre-transplant serial donor lymphocyte infusions to eliminate CMV","volume":"9","author":"Schwinger","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0276","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/pathogens12030440","article-title":"Infections in DNA repair defects","volume":"12","author":"Yilmaz Demirdag","year":"2023","journal-title":"Pathogens"},{"issue":"6199","key":"10.1016\/j.anai.2025.10.026_bib0277","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/336577a0","article-title":"Localization of an Ataxia-telangiectasia gene to chromosome 11q22-23","volume":"336","author":"Gatti","year":"1988","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0278","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/1744666X.2020.1810570","article-title":"Ataxia-telangiectasia: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management","volume":"16","author":"Amirifar","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"7787","key":"10.1016\/j.anai.2025.10.026_bib0279","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(72)92717-1","article-title":"Serum-alpha-fetoprotein levels in patients with Ataxia-telangiectasia","volume":"2","author":"Waldmann","year":"1972","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0280","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaip.2020.08.008","article-title":"Functional confirmation of DNA repair defect in ataxia telangiectasia (AT) infants identified by newborn screening for severe combined immunodeficiency (NBS SCID)","volume":"9","author":"Barmettler","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"15","key":"10.1016\/j.anai.2025.10.026_bib0281","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/bloodadvances.2018016113","article-title":"Application of a radiosensitivity flow assay in a patient with DNA ligase 4 deficiency","volume":"2","author":"Buchbinder","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0282","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ejhg.2013.40","article-title":"Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects","volume":"21","author":"Weemaes","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"1-2","key":"10.1016\/j.anai.2025.10.026_bib0283","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000015590","article-title":"DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients","volume":"89","author":"Tuck-Muller","year":"2000","journal-title":"Cytogenet Cell Genet"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0284","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10875-022-01418-y","article-title":"Clinical practice guidelines for the immunological management of chromosome 22q11.2 deletion syndrome and other defects in thymic development","volume":"43","author":"Mustillo","year":"2023","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e3182060469","article-title":"Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"90","author":"McDonald-McGinn","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0286","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/imr.13306","article-title":"Primary and secondary defects of the thymus","volume":"322","author":"Dinges","year":"2024","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0287","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.alit.2021.07.007","article-title":"Hyper-IgE syndrome, 2021 update","volume":"70","author":"Minegishi","year":"2021","journal-title":"Allergol Int"},{"issue":"15","key":"10.1016\/j.anai.2025.10.026_bib0288","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2011-09-378158","article-title":"The phenotype of human STK4 deficiency","volume":"119","author":"Abdollahpour","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0289","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaci.2014.02.023","article-title":"Flow cytometry diagnosis of dedicator of cytokinesis 8 (DOCK8) deficiency","volume":"134","author":"Pai","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0291","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clim.2018.07.011","article-title":"Diagnosis of DOCK8 deficiency using flow cytometry Biomarkers: an Egyptian Center experience","volume":"195","author":"Meshaal","year":"2018","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0292","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/497708","article-title":"Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator","volume":"77","author":"Thiel","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0293","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1053\/jpsu.2002.36189","article-title":"Hirschsprung's disease in cartilage-hair hypoplasia has poor prognosis","volume":"37","author":"M\u00e4kitie","year":"2002","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.anai.2025.10.026_bib0294","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1004694","article-title":"Lymphomas in cartilage-hair hypoplasia - A case series of 16 patients reveals advanced stage DLBCL as the most common form","volume":"13","author":"Kukkola","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0295","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jmg.29.9.652","article-title":"Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients","volume":"29","author":"M\u00e4kitie","year":"1992","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0296","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1111\/sji.12913","article-title":"Immunodeficiency in cartilage-hair hypoplasia: pathogenesis, clinical course and management","volume":"92","author":"Vakkilainen","year":"2020","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0297","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jaci.2016.11.051","article-title":"Defects in lymphocyte telomere homeostasis contribute to cellular immune phenotype in patients with cartilage-hair hypoplasia","volume":"140","author":"Aubert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0298","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/jmedgenet-2016-104279","article-title":"Decreased telomere length in children with cartilage-hair hypoplasia","volume":"54","author":"Kostjukovits","year":"2017","journal-title":"J Med Genet"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0299","doi-asserted-by":"crossref","first-page":"e2358","DOI":"10.1073\/pnas.1720427115","article-title":"Diagnostic utility of telomere length testing in a hospital-based setting","volume":"115","author":"Alder","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"10.1016\/j.anai.2025.10.026_bib0300","first-page":"59","article-title":"Telomere length measurement-caveats and a critical assessment of the available technologies and tools","volume":"730","author":"Aubert","year":"2012","journal-title":"Mutat Res"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0301","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12938","article-title":"Diseases caused by mutations in ORAI1 and STIM1","volume":"1356","author":"Lacruz","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.anai.2025.10.026_bib0302","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.critrevonc.2018.10.003","article-title":"Congenital neutropenia and primary immunodeficiency diseases","volume":"133","author":"Spoor","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0303","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaci.2018.09.018","article-title":"Neutropenia as a sign of immunodeficiency","volume":"143","author":"Sullivan","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0304","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.anai.2025.10.026_bib0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.653932","article-title":"Neutrophil elastase defects in congenital neutropenia","volume":"12","author":"Rydzynska","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0306","first-page":"16","article-title":"Lessons from rare maladies: leukocyte adhesion deficiency syndromes","volume":"20","author":"Harris","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.anai.2025.10.026_bib0307","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2011.06389.x","article-title":"Leukocyte adhesion deficiencies","volume":"1250","author":"Hanna","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0308","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jaip.2017.12.008","article-title":"Leukocyte adhesion deficiency-I: A comprehensive review of all published cases","volume":"6","author":"Almarza Novoa","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0309","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1073\/pnas.080074897","article-title":"Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation","volume":"97","author":"Ambruso","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3-4","key":"10.1016\/j.anai.2025.10.026_bib0310","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1155\/2010\/380291","article-title":"Rac GTPases in human diseases","volume":"29","author":"Pai","year":"2010","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0311","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/imr.13308","article-title":"Functional neutrophil disorders: chronic granulomatous disease and beyond","volume":"322","author":"Zerbe","year":"2024","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0312","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ibd\/izz259","article-title":"Very early onset inflammatory bowel disease: A clinical approach with a focus on the role of genetics and underlying immune deficiencies","volume":"26","author":"Ouahed","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.anai.2025.10.026_bib0313","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2025.113820","article-title":"Functional assays for the diagnosis of chronic granulomatous disease","volume":"537","author":"Priel","year":"2025","journal-title":"J Immunol Methods"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0314","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.jaip.2021.05.004","article-title":"A toolkit and framework for optimal laboratory evaluation of individuals with suspected primary immunodeficiency","volume":"9","author":"Knight","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0315","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaci.2017.02.029","article-title":"Inflammatory and autoimmune manifestations in X-linked carriers of chronic granulomatous disease in the United Kingdom","volume":"140","author":"Battersby","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0316","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1373\/clinchem.2006.083444","article-title":"Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD","volume":"53","author":"Mauch","year":"2007","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0317","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaci.2016.04.041","article-title":"Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis","volume":"139","author":"Siler","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0318","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210501","article-title":"Impaired respiratory burst contributes to infections in PKC\u03b4-deficient patients","volume":"218","author":"Neehus","year":"2021","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0319","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood.2019004465","article-title":"Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor","volume":"136","author":"Wortmann","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0320","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10875-019-00712-6","article-title":"NAPDH oxidase-specific flow cytometry allows for rapid genetic triage and classification of novel variants in chronic granulomatous disease","volume":"40","author":"Sacco","year":"2020","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0321","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00725-2024","article-title":"European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosis","volume":"64","author":"McCarthy","year":"2024","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0322","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-0039-3402727","article-title":"Pulmonary alveolar proteinosis syndrome","volume":"41","author":"Kelly","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0323","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jinf.2012.03.020","article-title":"Opportunistic infections in patients with pulmonary alveolar proteinosis","volume":"65","author":"Punatar","year":"2012","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0324","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","article-title":"Pulmonary alveolar proteinosis","volume":"5","author":"Trapnell","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0325","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.202112-2742SO","article-title":"Autoimmune pulmonary alveolar proteinosis","volume":"205","author":"McCarthy","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2025.10.026_bib0326","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.752856","article-title":"The role of GM-CSF autoantibodies in infection and autoimmune pulmonary alveolar proteinosis: a concise review","volume":"12","author":"Ataya","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0327","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3389\/fimmu.2019.01517","article-title":"Functional analysis of anti-cytokine autoantibodies using flow cytometry","volume":"10","author":"Merkel","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0328","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/10408363.2018.1444580","article-title":"Laboratory evaluation of the IFN-\u03b3 circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease","volume":"55","author":"Esteve-Sol\u00e9","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"21","key":"10.1016\/j.anai.2025.10.026_bib0329","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.0000000000000999","article-title":"TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk","volume":"83","author":"Lim","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0330","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.jaci.2025.01.030","article-title":"Clinical, immunologic and genetic characteristics of 148 patients with natural killer cell deficiency","volume":"155","author":"Abdalgani","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"6-7","key":"10.1016\/j.anai.2025.10.026_bib0331","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00439-020-02127-5","article-title":"Herpes simplex virus encephalitis of childhood: inborn errors of central nervous system cell-intrinsic immunity","volume":"139","author":"Zhang","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.anai.2025.10.026_bib0332","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.coi.2021.06.017","article-title":"Human inborn errors of immunity to oncogenic viruses","volume":"72","author":"B\u00e9ziat","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0333","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3389\/fmicb.2018.01222","article-title":"Epidermodysplasia verruciformis: inborn errors of immunity to human beta-papillomaviruses","volume":"9","author":"de Jong","year":"2018","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0334","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166283","article-title":"Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs","volume":"133","author":"Casanova","year":"2023","journal-title":"J Clin Invest"},{"issue":"25","key":"10.1016\/j.anai.2025.10.026_bib0335","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0336","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168321","article-title":"Human inherited complete STAT2 deficiency underlies inflammatory viral diseases","volume":"133","author":"Bucciol","year":"2023","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0337","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-022-00399-x","article-title":"Asplenia and spleen hypofunction","volume":"8","author":"Lenti","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0338","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s13023-022-02515-2","article-title":"A multi-disciplinary, comprehensive approach to management of children with heterotaxy","volume":"17","author":"Saba","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0339","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CVI.13.1.68-76.2006","article-title":"Development of a clinical assay to evaluate toll-like receptor function","volume":"13","author":"Deering","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0340","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cei.12746","article-title":"Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of diagnostic utility","volume":"184","author":"Dhalla","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0341","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"issue":"20","key":"10.1016\/j.anai.2025.10.026_bib0342","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa2312665","article-title":"The role of interferon-\u03b3 in autoimmune polyendocrine syndrome Type 1","volume":"390","author":"Oikonomou","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0343","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJMc0911468","article-title":"Dectin-1 deficiency and mucocutaneous fungal infections","volume":"362","author":"Mar\u00f3di","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0344","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaip.2023.04.015","article-title":"The Th17\/IL-17 axis and host defense against fungal infections","volume":"11","author":"Tangye","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0345","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0346","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","article-title":"Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections","volume":"175","author":"Patel","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0347","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of anti-interferon-\u03b3 autoantibody-associated immunodeficiency syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0348","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0349","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Sarma","year":"2011","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0350","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2015.03.007","article-title":"Clinical presentation of human C1q deficiency: how much of a lupus?","volume":"67","author":"Stegert","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0351","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway","volume":"7","author":"Macedo","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0352","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.md.0000152371.22747.1e","article-title":"Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease","volume":"84","author":"J\u00f6nsson","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0353","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s10875-020-00754-1","article-title":"European Society for Immunodeficiencies (ESID) and European reference network on rare primary immunodeficiency, autoinflammatory and autoimmune diseases (ERN RITA) complement guideline: deficiencies, diagnosis, and management","volume":"40","author":"Brodszki","year":"2020","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0354","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.molimm.2014.06.032","article-title":"Genetic variants in the complement system predisposing to age-related macular degeneration: a review","volume":"61","author":"Schramm","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0356","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.anai.2014.04.003","article-title":"Properdin deficiency-associated bronchiectasis","volume":"112","author":"Lee","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0357","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1074\/jbc.M508928200","article-title":"The role of properdin in the assembly of the alternative pathway C3 convertases of complement","volume":"281","author":"Hourcade","year":"2006","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0358","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10875-020-00906-3","article-title":"A novel case of complement factor B deficiency","volume":"41","author":"Gauthier","year":"2021","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0359","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1172\/JCI114384","article-title":"Complete and partial deficiencies of complement factor D in a Dutch family","volume":"84","author":"Hiemstra","year":"1989","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0360","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20040111","article-title":"A population-based study of morbidity and mortality in mannose-binding lectin deficiency","volume":"199","author":"Dahl","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.anai.2025.10.026_bib0361","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585243","article-title":"The influence of the lectin complement activation on infections of the respiratory system","volume":"11","author":"\u015awierzko","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0362","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/INF.0b013e31811ffe6a","article-title":"Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients","volume":"26","author":"Schlapbach","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0363","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/ajh.24209","article-title":"Laboratory tests for disorders of complement and complement regulatory proteins","volume":"90","author":"Shih","year":"2015","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0364","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.imbio.2016.06.008","article-title":"Complement analysis 2016: clinical indications, laboratory diagnostics and quality control","volume":"221","author":"Proh\u00e1szka","year":"2016","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0365","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.molimm.2014.06.030","article-title":"Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach","volume":"61","author":"Grumach","year":"2014","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0366","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12890","article-title":"Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders","volume":"187","author":"Wehling","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0367","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0368","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/joim.12338","article-title":"Complement regulators in human disease: lessons from modern genetics","volume":"277","author":"Liszewski","year":"2015","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0369","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.kint.2018.02.029","article-title":"Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome","volume":"94","author":"Schaefer","year":"2018","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0370","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.anai.2025.10.026_bib0371","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2016.01.003","article-title":"Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome","volume":"71","author":"Szarvas","year":"2016","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0372","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI118515","article-title":"The molecular basis of hereditary complement factor I deficiency","volume":"97","author":"Vyse","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.anai.2025.10.026_bib0373","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2016.07.017","article-title":"Thrombomodulin enhances complement regulation through strong affinity interactions with factor H and C3b-factor H complex","volume":"145","author":"Heurich","year":"2016","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0374","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0375","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.anai.2025.10.026_bib0376","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fimmu.2018.00612","article-title":"Overactivity of alternative pathway convertases in patients with complement-mediated renal diseases","volume":"9","author":"Michels","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0377","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/j.ajkd.2014.10.023","article-title":"C3 glomerulonephritis associated with complement factor B mutation","volume":"65","author":"Sethi","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0378","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2016030343","article-title":"Anti-factor B and anti-C3b autoantibodies in C3 glomerulopathy and Ig-associated membranoproliferative GN","volume":"28","author":"Marinozzi","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"10.1016\/j.anai.2025.10.026_bib0379","first-page":"3861","article-title":"Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels","volume":"24","author":"Kavanagh","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0380","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-3083.2006.01729.x","article-title":"Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H","volume":"63","author":"Reis","year":"2006","journal-title":"Scand J Immunol"},{"issue":"18","key":"10.1016\/j.anai.2025.10.026_bib0381","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0382","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1056\/NEJMoa1615887","article-title":"CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis","volume":"377","author":"Ozen","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0383","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0037-1604483","article-title":"Neonatal-onset recurrent Guillain-Barr\u00e9 syndrome-like disease: clues for inherited CD59 deficiency","volume":"48","author":"Ardicli","year":"2017","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0384","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0385","doi-asserted-by":"crossref","first-page":"e99128","DOI":"10.1172\/jci.insight.99128","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0386","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2005.02988.x","article-title":"Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family","volume":"143","author":"Grumach","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0387","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fimmu.2018.00500","article-title":"Functional complement analysis can predict genetic testing results and long-term outcome in patients with complement deficiencies","volume":"9","author":"Blazina","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0388","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molimm.2016.11.016","article-title":"The complement system in age-related macular degeneration: a review of rare genetic variants and implications for personalized treatment","volume":"84","author":"Geerlings","year":"2017","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0389","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2141.2012.09168.x","article-title":"The use of \u2018real-time\u2019 complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathies","volume":"158","author":"Proh\u00e1szka","year":"2012","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0390","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab","volume":"370","author":"Nishimura","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0391","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2013.090001","article-title":"Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria","volume":"99","author":"Rondelli","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0392","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cei.13620","article-title":"Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: an intriguing challenge","volume":"205","author":"Costagliola","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0393","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10875-021-01177-2","article-title":"The immune deficiency and dysregulation activity (IDDA2.1 'Kaleidoscope') score and other clinical measures in inborn errors of immunity","volume":"42","author":"Seidel","year":"2022","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0394","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaip.2020.10.057","article-title":"Patterns of immune dysregulation in primary immunodeficiencies: A systematic review","volume":"9","author":"Mauracher","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0395","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/MOP.0000000000000833","article-title":"Autoimmunity as a continuum in primary immunodeficiency","volume":"31","author":"Walter","year":"2019","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.anai.2025.10.026_bib0396","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.725587","article-title":"Novel discoveries in immune dysregulation in inborn errors of immunity","volume":"12","author":"Ren","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0397","doi-asserted-by":"crossref","first-page":"e27619","DOI":"10.1002\/pbc.27619","article-title":"Primary immune regulatory disorders for the pediatric hematologist and oncologist: a case-based review","volume":"66","author":"Chandrakasan","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0398","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/cmi.2016.25","article-title":"Clash of the cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses","volume":"14","author":"Mayer-Barber","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0399","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/jcm10010128","article-title":"Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today?","volume":"10","author":"Welzel","year":"2021","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0400","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"10.1016\/j.anai.2025.10.026_bib0401","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood.2024025077","article-title":"Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited","volume":"144","author":"Henter","year":"2024","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0402","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jaip.2020.04.070","article-title":"Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome","volume":"8","author":"Jamee","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0403","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2023.11.021","article-title":"IPEX syndrome from diagnosis to cure, learning along the way","volume":"153","author":"Bacchetta","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"14","key":"10.1016\/j.anai.2025.10.026_bib0404","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.anai.2025.10.026_bib0405","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671755","article-title":"Primary immune regulatory disorders with an autoimmune lymphoproliferative syndrome-like phenotype: immunologic evaluation, early diagnosis and management","volume":"12","author":"L\u00f3pez-Nevado","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0406","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/S2352-3026(23)00362-9","article-title":"Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study","volume":"11","author":"H\u00e4gele","year":"2024","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0407","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaci.2023.11.004","article-title":"Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders","volume":"153","author":"Magerus","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0408","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.723532","article-title":"Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"9","author":"Ferr\u00e9","year":"2021","journal-title":"Front Pediatr"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0409","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11882-017-0724-z","article-title":"Inflammatory bowel disease in primary immunodeficiencies","volume":"17","author":"Kelsen","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0410","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cei\/uxac040","article-title":"The clinical, molecular, and therapeutic features of patients with IL10\/IL10R deficiency: a systematic review","volume":"208","author":"Sharifinejad","year":"2022","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0411","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10875-018-0492-0","article-title":"Complications associated with underweight primary immunodeficiency patients: prevalence and associations within the USIDNET registry","volume":"38","author":"Ruffner","year":"2018","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0412","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000128661","article-title":"Vitamin D deficiency in the absence of enteropathy in three cases with common variable immunodeficiency","volume":"147","author":"Ardeniz","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0413","first-page":"427","article-title":"Assessment of nutritional status: vitamin A and zinc in patients with common variable immunodeficiency","volume":"22","author":"dos Santos-Valente","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0414","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12865-020-00372-x","article-title":"Assessment of weight and height of patients with primary immunodeficiency disorders and group of children with recurrent respiratory tract infections","volume":"21","author":"Pieniawska-\u015amiech","year":"2020","journal-title":"BMC Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0415","first-page":"189","article-title":"A study of malnutrition in Iranian patients with primary antibody deficiency","volume":"3","author":"Kouhkan","year":"2004","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0416","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cgh.2013.02.024","article-title":"Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency","volume":"11","author":"Agarwal","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"15","key":"10.1016\/j.anai.2025.10.026_bib0417","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/blood-2013-01-480665","article-title":"Innate immune control of EBV-infected B cells by invariant natural killer T cells","volume":"122","author":"Chung","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0418","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.1800171","article-title":"Cytomegalovirus: shape-shifting the immune system","volume":"200","author":"Picarda","year":"2018","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0419","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jcag\/gwz004","article-title":"Gastrointestinal disease in patients with common variable immunodeficiency: A retrospective observational study","volume":"3","author":"Khan","year":"2020","journal-title":"J Can Assoc Gastroenterol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0420","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMc1301022","article-title":"Norovirus gastroenteritis in immunocompromised patients","volume":"368","author":"Haessler","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0421","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/cid\/ciy845","article-title":"Clostridium difficile in immunocompromised hosts: a review of epidemiology, risk factors, treatment, and prevention","volume":"68","author":"Revolinski","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0422","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/imr.12725","article-title":"Emerging insights into human health and NK cell biology from the study of NK cell deficiencies","volume":"287","author":"Mace","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.anai.2025.10.026_bib0423","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fimmu.2018.00237","article-title":"Herpesviruses in the activated Phosphatidylinositol-3-Kinase-\u03b4 syndrome","volume":"9","author":"Cohen","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0424","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.cmi.2022.02.023","article-title":"Genetic susceptibility to viral disease in humans","volume":"28","author":"Mogensen","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.anai.2025.10.026_bib0425","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2018.07.012","article-title":"High frequencies of asymptomatic Epstein-Barr virus viremia in affected and unaffected individuals with CTLA4 mutations","volume":"195","author":"Hoshino","year":"2018","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0426","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/QCO.0000000000000797","article-title":"Cytomegalovirus in primary immunodeficiency","volume":"34","author":"Godsell","year":"2021","journal-title":"Curr Opin Infect Dis"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0427","doi-asserted-by":"crossref","first-page":"e2705","DOI":"10.1093\/cid\/ciaa1274","article-title":"Primary and acquired immunodeficiencies associated with severe varicella-zoster virus infections","volume":"73","author":"Ansari","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0428","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaci.2012.07.049","article-title":"Warts and all: human papillomavirus in primary immunodeficiencies","volume":"130","author":"Leiding","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0429","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1002\/ski2.98","article-title":"Consideration of underlying immunodeficiency in refractory or recalcitrant warts: a review of the literature","volume":"2","author":"Zampella","year":"2022","journal-title":"Skin Health Dis"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0430","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MPG.0b013e318054b09b","article-title":"Cryptosporidium infection in patients with primary immunodeficiencies","volume":"45","author":"Wolska-Kusnierz","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0431","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.md.0000133624.65946.40","article-title":"Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature","volume":"83","author":"Michel","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"13","key":"10.1016\/j.anai.2025.10.026_bib0432","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","article-title":"Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations","volume":"123","author":"Price","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0433","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000535258","article-title":"Autoimmune cytopenias are highly associated with inborn errors of immunity and they may be the initial presentations in cases without severe infections","volume":"185","author":"Taskin","year":"2024","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0434","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790455","article-title":"Autoimmune cytopenias and dysregulated immunophenotype act as warning signs of inborn errors of immunity: results from a prospective study","volume":"12","author":"Schiavo","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0435","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0436","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10875-017-0456-9","article-title":"Cunningham-Rundles C. Autoimmune cytopenias and associated conditions in CVID: a report from the USIDNET registry","volume":"38","author":"Feuille","year":"2018","journal-title":"J Clin Immunol"},{"issue":"18","key":"10.1016\/j.anai.2025.10.026_bib0437","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0438","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/bjh.15178","article-title":"Clinical features and therapeutic challenges of cytopenias belonging to alps and alps-related (ARS) phenotype","volume":"184","author":"Palmisani","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anai.2025.10.026_bib0439","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3389\/fimmu.2018.02411","article-title":"Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"9","author":"Gambineri","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0440","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0441","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI131116","article-title":"Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease","volume":"130","author":"Ravell","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0442","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41436-019-0623-x","article-title":"Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals","volume":"22","author":"Margot","year":"2020","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0443","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/ajmg.a.61793","article-title":"Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome","volume":"182","author":"Murakami","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0444","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: A systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0445","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0446","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1182\/blood-2012-08-448118","article-title":"Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome","volume":"121","author":"Mahlaoui","year":"2013","journal-title":"Blood"},{"issue":"5 Pt 1","key":"10.1016\/j.anai.2025.10.026_bib0447","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.111.5.e622","article-title":"Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients","volume":"111","author":"Dupuis-Girod","year":"2003","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0448","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jpeds.2014.01.056","article-title":"Clinical features and follow-up in patients with 22q11.2 deletion syndrome","volume":"164","author":"Cancrini","year":"2014","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0449","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jaip.2019.03.014","article-title":"Immunophenotype anomalies predict the development of autoimmune cytopenia in 22q11.2 deletion syndrome","volume":"7","author":"Montin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0450","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10875-020-00883-7","article-title":"Clinical spectrum of Ras-associated autoimmune Leukoproliferative disorder (RALD)","volume":"41","author":"Neven","year":"2021","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0451","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/ACI.0000000000000689","article-title":"Primary immune regulatory disorders: a growing universe of immune dysregulation","volume":"20","author":"Chan","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0452","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0453","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103012","article-title":"Autoantibodies and SARS-CoV2 infection: the spectrum from association to clinical implication: report of the 15th Dresden Symposium on Autoantibodies","volume":"21","author":"Damoiseaux","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"6515","key":"10.1016\/j.anai.2025.10.026_bib0454","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0455","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. Children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2025.10.026_bib0456","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.665322","article-title":"Diagnostic and predictive contribution of autoantibodies screening in a large series of patients with primary immunodeficiencies","volume":"12","author":"Tahiat","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0457","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jth.14419","article-title":"The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test","volume":"17","author":"Vrbensky","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.anai.2025.10.026_bib0458","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.rinim.2013.10.003","article-title":"Predictive value of antinuclear antibodies in autoimmune diseases classified by clinical criteria: analytical study in a specialized health institute, one year follow-up","volume":"5","author":"Soto","year":"2015","journal-title":"Results Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0459","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841126","article-title":"Autoantibodies against proteins previously associated with autoimmunity in adult and pediatric patients with COVID-19 and children with MIS-C","volume":"13","author":"Burbelo","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0460","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00415-019-09614-4","article-title":"Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity","volume":"267","author":"Gr\u00fcter","year":"2020","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0461","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pathol.2023.05.020","article-title":"Intravenous immunoglobulin as a source of passively acquired thyroid autoantibodies","volume":"56","author":"Salib","year":"2024","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0462","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/trf.17766","article-title":"Autoantibody profiles in intravenous immunoglobulin preparations: A possible cause of mistaken autoimmunity diagnosis","volume":"64","author":"Miyamoto","year":"2024","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0463","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13223-022-00661-7","article-title":"Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review","volume":"18","author":"Lee","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0464","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","article-title":"How I treat common variable immune deficiency","volume":"116","author":"Cunningham-Rundles","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0465","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/106698110X12595770849362","article-title":"The lost art of the clinical examination: an overemphasis on clinical special tests","volume":"18","author":"Cook","year":"2010","journal-title":"J Man Manip Ther"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0466","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cei.13272","article-title":"British Society for Immunology\/United Kingdom Primary Immunodeficiency Network consensus statement on managing non-infectious complications of common variable immunodeficiency disorders","volume":"196","author":"Bethune","year":"2019","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0467","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1183\/09031936.00118414","article-title":"Pulmonary manifestations in adult patients with chronic granulomatous disease","volume":"45","author":"Salvator","year":"2015","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0468","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jaip.2016.08.005","article-title":"Lung disease in primary antibody deficiencies","volume":"4","author":"Schussler","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0469","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.anai.2014.04.024","article-title":"Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations","volume":"113","author":"Maglione","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0470","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaci.2013.08.022","article-title":"Cunningham-Rundles C. Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency","volume":"133","author":"Maglione","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0471","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s10875-023-01552-1","article-title":"Common and uncommon CT findings in CVID-related GL-ILD: correlations with clinical parameters, therapeutic decisions and potential implications in the differential diagnosis","volume":"43","author":"Scarpa","year":"2023","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0472","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jaip.2023.12.047","article-title":"Pulmonary computed tomography screening frequency in primary antibody deficiency","volume":"12","author":"Smits","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"138","key":"10.1016\/j.anai.2025.10.026_bib0473","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1183\/16000617.0066-2015","article-title":"ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia","volume":"24","author":"Bhatt","year":"2015","journal-title":"Eur Respir Rev"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0474","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1378\/chest.10-3147","article-title":"Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity","volume":"140","author":"Serra","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0475","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4187\/respcare.06334","article-title":"Exertional desaturation and prescription of ambulatory oxygen therapy in interstitial lung disease","volume":"64","author":"Khor","year":"2019","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0476","first-page":"111","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2025.10.026_bib0477","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.834137","article-title":"Contribution of Helicobacter pylori to the inflammatory complications of common variable immunodeficiency","volume":"13","author":"Motta-Raymundo","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0478","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0479","doi-asserted-by":"crossref","first-page":"648","DOI":"10.14309\/ajg.0000000000000140","article-title":"A high prevalence of gastrointestinal manifestations in common variable immunodeficiency","volume":"114","author":"Pikkarainen","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0480","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1128\/JCM.01637-14","article-title":"Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens","volume":"52","author":"Khare","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.anai.2025.10.026_bib0481","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/CEG.S136803","article-title":"Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states","volume":"10","author":"Levitt","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0482","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clim.2011.10.001","article-title":"Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency","volume":"142","author":"Shimizu","year":"2012","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0483","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12016-013-8377-8","article-title":"Skin manifestations of primary immune deficiency","volume":"46","author":"Lehman","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0484","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jamadermatol.2022.0828","article-title":"Association of persistent rubella virus with idiopathic skin granulomas in clinically immunocompetent adults","volume":"158","author":"Wanat","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0485","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1016\/j.jaip.2023.06.037","article-title":"Cutaneous findings in inborn errors of immunity: an immunologist's perspective","volume":"11","author":"Cagdas","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.10.026_bib0486","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786241","article-title":"Endocrinopathies in inbron errors of immunity","volume":"12","author":"Takasawa","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0487","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1399-3038.2011.01187.x","article-title":"Osteoporosis: an ignored complication of CVID","volume":"22","author":"Baris","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0488","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10875-013-9982-2","article-title":"Bone density and fractures in autosomal dominant hyper IgE syndrome","volume":"34","author":"Sowerwine","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0489","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928062","article-title":"Secondary immune deficiency and primary immune deficiency crossovers: hematological malignancies and autoimmune diseases","volume":"13","author":"Ballow","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0490","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: cancer incidence in the United States Immune Deficiency Network Registry","volume":"141","author":"Mayor","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0491","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MOH.0b013e328302c7b6","article-title":"Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics","volume":"15","author":"Chua","year":"2008","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0492","first-page":"313","article-title":"Inborn errors of immunity and cancer","volume":"10","author":"Tiri","year":"2021","journal-title":"Biology (Basel)"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0493","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jaci.2007.07.044","article-title":"Long-term follow-up of patients with primary immunodeficiencies","volume":"120","author":"Chinen","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0494","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2009.02.057","article-title":"Clinical radiation sensitivity with DNA repair disorders: an overview","volume":"74","author":"Pollard","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"50","key":"10.1016\/j.anai.2025.10.026_bib0495","doi-asserted-by":"crossref","first-page":"e1802","DOI":"10.1503\/cmaj.201085","article-title":"The efficacy and safety of sunscreen use for the prevention of skin cancer","volume":"192","author":"Sander","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.anai.2025.10.026_bib0496","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1112513","article-title":"Human papillomavirus in the setting of immunodeficiency: pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk","volume":"14","author":"Hewavisenti","year":"2023","journal-title":"Front Immunol"},{"issue":"30","key":"10.1016\/j.anai.2025.10.026_bib0497","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1016\/j.vaccine.2010.04.057","article-title":"A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome","volume":"28","author":"Handisurya","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0498","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/hematology.2021000284","article-title":"Diagnosis and therapeutic decision-making for the neutropenic patient","volume":"2021","author":"Connelly","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0499","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/RLU.0000000000002816","article-title":"18F-FDG PET imaging features of patients with autoimmune lymphoproliferative syndrome","volume":"44","author":"Carrasquillo","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.anai.2025.10.026_bib0500","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fimmu.2016.00365","article-title":"Cancers related to immunodeficiencies: update and perspectives","volume":"7","author":"Mortaz","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0501","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000452082","article-title":"Bloom's syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition","volume":"8","author":"Cunniff","year":"2017","journal-title":"Mol Syndromol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0502","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s10875-020-00769-8","article-title":"Lymphoproliferative disease in CVID: a report of types and frequencies from a US patient registry","volume":"40","author":"Yakaboski","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0503","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2017.01869","article-title":"GATA2 deficiency and Epstein-Barr virus disease","volume":"8","author":"Cohen","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0504","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/pcmr.12671","article-title":"Melanoma in patients with GATA2 deficiency","volume":"31","author":"Nguyen","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0505","doi-asserted-by":"crossref","first-page":"85","DOI":"10.15586\/aei.v52i1.961","article-title":"Neurological involvement in patients with primary immunodeficiency","volume":"52","author":"Kose","year":"2024","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0506","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2008-04-151332","article-title":"Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies","volume":"112","author":"Titman","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0507","first-page":"A14","article-title":"The vital link between chronic disease and depressive disorders","volume":"2","author":"Chapman","year":"2005","journal-title":"Prev Chronic Dis"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0508","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10875-018-0481-3","article-title":"Investigating the effectiveness, acceptability and impact on healthcare usage of providing a cognitive-behavioural based psychological therapy service for patients with primary antibody deficiency","volume":"38","author":"Campbell","year":"2018","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0509","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10875-022-01207-7","article-title":"Psychological symptoms in primary immunodeficiencies: a common comorbidity?","volume":"42","author":"Manusama","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0510","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fimmu.2014.00605","article-title":"Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies","volume":"5","author":"Tabolli","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0511","article-title":"Self-reported cognitive impairment in individuals with Primary Immunodeficiency Disease","volume":"9","author":"Sowers","year":"2020","journal-title":"Brain Behav Immun Health"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0512","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jamapsychiatry.2020.1260","article-title":"Association of primary humoral immunodeficiencies with psychiatric disorders and suicidal behavior and the role of autoimmune diseases","volume":"77","author":"Isung","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0513","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200088","article-title":"Neurologic manifestations of common variable immunodeficiency: impact on quality of life","volume":"10","author":"De Almeida","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0514","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s10875-021-01013-7","article-title":"Severe fatigue is common among pediatric patients with primary immunodeficiency and is not related to disease activity","volume":"41","author":"Nijhof","year":"2021","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0515","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/cei.13210","article-title":"Fatigue and the wear-off in adult patients with common variable immunodeficiency","volume":"194","author":"Hajjar","year":"2018","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0516","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10875-016-0367-1","article-title":"Increased incidence of fatigue in patients with primary immunodeficiency disorders: prevalence and associations within the US Immunodeficiency Network registry","volume":"37","author":"Hajjar","year":"2017","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0517","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0518","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1054-139X(01)00333-0","article-title":"The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients","volume":"30","author":"Johnson","year":"2002","journal-title":"J Adolesc Health"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0519","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247941","article-title":"Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): a health-economic assessment","volume":"16","author":"van Wilder","year":"2021","journal-title":"PLoS One"},{"issue":"3S","key":"10.1016\/j.anai.2025.10.026_bib0520","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0521","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2249.2012.04588.x","article-title":"Comparison of American and European practices in the management of patients with primary immunodeficiencies","volume":"169","author":"Hernandez-Trujillo","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0522","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2249.2003.02199.x","article-title":"Immunology Nurses Study. Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin","volume":"133","author":"Brennan","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"1-3","key":"10.1016\/j.anai.2025.10.026_bib0523","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12026-007-0003-5","article-title":"Safety of IGIV therapy and infusion-related adverse events","volume":"38","author":"Ballow","year":"2007","journal-title":"Immunol Res"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0524","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tmrv.2013.05.004","article-title":"Adverse effects of human immunoglobulin therapy","volume":"27","author":"Stiehm","year":"2013","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0525","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.autrev.2015.09.002","article-title":"Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence","volume":"15","author":"Cherin","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0526","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0091-6749(03)01780-9","article-title":"Acute thromboembolic events associated with intravenous immunoglobulin infusion in antibody-deficient patients","volume":"112","author":"Brown","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0527","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2340\/00015555-0900","article-title":"Not all intravenous immunoglobulin preparations are equally well tolerated","volume":"90","author":"Feldmeyer","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0528","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7861\/clinmedicine.19-3-201","article-title":"Switching immunoglobulin products, what are the implications? Result of 2018 census of immunology centres","volume":"19","author":"Bethune","year":"2019","journal-title":"Clin Med (Lond)"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0529","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/jdv.14671","article-title":"Effect of intravenous immunoglobulin administration on erythrocyte and leucocyte parameters","volume":"32","author":"Cicha","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0530","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/trf.17028","article-title":"Incidence and risk factors for intravenous immunoglobulin-related hemolysis: a systematic review of clinical trial and real-world populations","volume":"62","author":"Cuesta","year":"2022","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0531","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000354893","article-title":"Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk","volume":"38","author":"Dantal","year":"2013","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0532","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5414\/CN106824","article-title":"Intravenous gammaglobulin-associated renal impairment reported to the FDA: 2004-2009","volume":"76","author":"Lin","year":"2011","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0533","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/pds.2253","article-title":"French Association of Regional Pharmacovigilance Centers. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study","volume":"21","author":"Moulis","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"28","key":"10.1016\/j.anai.2025.10.026_bib0534","first-page":"505","article-title":"Outbreak of hepatitis C associated with intravenous immunoglobulin administration\u2013United States, October 1993-June 1994","volume":"43","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0535","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1423-0410.2007.01016.x","article-title":"A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity","volume":"94","author":"Poelsler","year":"2008","journal-title":"Vox Sang"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0536","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0537","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti","year":"2011","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0538","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100068","article-title":"Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: a systematic review and meta-analysis of clinical studies","volume":"12","author":"Shrestha","year":"2019","journal-title":"World Allergy Organ J"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0539","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.anai.2013.06.013","article-title":"Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data","volume":"111","author":"Ballow","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0540","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/ACI.0b013e32834c22da","article-title":"Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose","volume":"11","author":"Berger","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0541","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3810\/pgm.2013.11.2712","article-title":"Pharmacokinetic modeling and simulation of biweekly subcutaneous immunoglobulin dosing in primary immunodeficiency","volume":"125","author":"Landersdorfer","year":"2013","journal-title":"Postgrad Med"},{"issue":"1-2","key":"10.1016\/j.anai.2025.10.026_bib0542","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13554-014-0018-0","article-title":"Enhancing patient flexibility of subcutaneous immunoglobulin G dosing: pharmacokinetic outcomes of various maintenance and loading regimens in the treatment of primary immunodeficiency","volume":"4","author":"Sidhu","year":"2014","journal-title":"Biol Ther"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0543","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s10875-013-9876-3","article-title":"Bioavailability of IgG administered by the subcutaneous route","volume":"33","author":"Berger","year":"2013","journal-title":"J Clin Immunol"},{"issue":"suppl 2","key":"10.1016\/j.anai.2025.10.026_bib0544","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1007\/s10875-012-9838-1","article-title":"Using intravenous immunoglobulin (IVIG) to treat patients with primary immune deficiency disease","volume":"33","author":"Bonagura","year":"2013","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0545","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0546","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2249.2012.04594.x","article-title":"Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy","volume":"169","author":"Orange","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0547","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yapd.2010.08.005","article-title":"Therapeutic use of immunoglobulins","volume":"57","author":"Stiehm","year":"2010","journal-title":"Adv Pediatr"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0548","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM198602273140907","article-title":"Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA","volume":"314","author":"Burks","year":"1986","journal-title":"N Engl J Med"},{"issue":"1-3","key":"10.1016\/j.anai.2025.10.026_bib0549","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12016-024-09007-0","article-title":"Non-allergic hypersensitivity reactions to immunoglobulin preparations in antibody deficiencies: what role for anti-IgA IgG and complement activation","volume":"67","author":"Collet","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0550","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaci.2011.06.047","article-title":"The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature","volume":"129","author":"Rachid","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0551","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/cei.12485","article-title":"Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease","volume":"179","author":"Jolles","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0552","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10875-008-9180-9","article-title":"Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin","volume":"28","author":"Fasth","year":"2008","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0553","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.iac.2020.04.002","article-title":"Nuts and bolts of subcutaneous therapy","volume":"40","author":"Duff","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.10.026_bib0554","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/jpids\/piy016","article-title":"Prevention of infectious complications in patients with chronic granulomatous disease","volume":"7","author":"Slack","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0555","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/infdis\/162.3.723","article-title":"Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease","volume":"162","author":"Margolis","year":"1990","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0556","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3476(83)80798-7","article-title":"Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease","volume":"103","author":"Weening","year":"1983","journal-title":"J Pediatr"},{"issue":"24","key":"10.1016\/j.anai.2025.10.026_bib0557","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0558","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaad.2018.08.010","article-title":"Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: a systematic review and meta-analysis","volume":"80","author":"Tang","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0559","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5500\/wjt.v11.i9.356","article-title":"Voriconazole-associated periostitis: pathophysiology, risk factors, clinical manifestations, diagnosis, and management","volume":"11","author":"Guarascio","year":"2021","journal-title":"World J Transplant"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0560","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"International Chronic Granulomatouse Disease Cooperative Disease Study GroupA controlled trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0561","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10875-022-01391-6","article-title":"Efficacy and safety of interferon-gamma in chronic granulomatous disease: a systematic review and meta-analysis","volume":"43","author":"Lugo Reyes","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0562","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1078976","article-title":"Case Report: nontuberculous mycobacterial infections in children with complete DiGeorge anomaly","volume":"14","author":"Hicks","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0563","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/ACI.0b013e328332be33","article-title":"Antimicrobial prophylaxis for primary immunodeficiencies","volume":"9","author":"Freeman","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0564","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clim.2009.10.003","article-title":"Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: a working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology","volume":"135","author":"Yong","year":"2010","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0565","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaip.2017.11.024","article-title":"Should antibiotic prophylaxis be routinely used in patients with antibody-mediated primary immunodeficiency?","volume":"6","author":"Ballow","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0566","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.rmed.2014.09.005","article-title":"Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions","volume":"108","author":"Haworth","year":"2014","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0567","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2019.01.051","article-title":"Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies","volume":"144","author":"Milito","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0568","article-title":"Infections with enterohepatic non-H. pylori Helicobacter species in X-linked agammaglobulinemia: clinical cases and review of the literature","volume":"11","author":"Romo-Gonzalez","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0569","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/cei.13345","article-title":"Transient hypogammaglobulinaemia of infancy: many patients recover in adolescence and adulthood","volume":"198","author":"Ameratunga","year":"2019","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0570","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10875-019-00716-2","article-title":"Prophylactic antibiotics versus immunoglobulin replacement in specific antibody deficiency","volume":"40","author":"Hajjar","year":"2020","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0571","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/hematology.2020000117","article-title":"Preventing infections in children and adults with asplenia","volume":"2020","author":"Lee","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0572","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CMR.00048-09","article-title":"Infections of people with complement deficiencies and patients who have undergone splenectomy","volume":"23","author":"Ram","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0573","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","article-title":"STAT3 hyper-IgE syndrome-an update and unanswered questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0574","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Med (Baltim)"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0575","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s10875-016-0291-4","article-title":"Hyper IgM syndrome: a report from the USIDNET registry","volume":"36","author":"Leven","year":"2016","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0576","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","article-title":"DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients","volume":"35","author":"Aydin","year":"2015","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0577","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10875-017-0453-z","article-title":"Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome","volume":"38","author":"Candotti","year":"2018","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0578","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/pathogens12020310","article-title":"Inborn errors of immunity predisposing to herpes simplex virus infections of the central nervous system","volume":"12","author":"Skouboe","year":"2023","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0579","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12879-020-05656-6","article-title":"Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program","volume":"21","author":"Gans","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0580","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0581","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220202","article-title":"Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency","volume":"219","author":"Campbell","year":"2022","journal-title":"J Exp Med"},{"issue":"7902","key":"10.1016\/j.anai.2025.10.026_bib0582","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","article-title":"Human genetic and immunological determinants of critical COVID-19 pneumonia","volume":"603","author":"Zhang","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0583","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/QCO.0000000000000910","article-title":"Antiviral therapies for influenza","volume":"36","author":"Chan","year":"2023","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0584","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S1473-3099(15)00089-4","article-title":"Hosts susceptibility to non-tuberculous mycobacterial infections","volume":"15","author":"Wu","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0585","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15586\/aei.v49i1.20","article-title":"Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches","volume":"49","author":"Egri","year":"2021","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"suppl","key":"10.1016\/j.anai.2025.10.026_bib0586","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jinf.2016.04.023","article-title":"Treatment options for chronic mucocutaneous candidiasis","volume":"72","author":"van de Veerdonk","year":"2016","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0587","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0588","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2015.07.003","article-title":"Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome","volume":"136","author":"Odio","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"18","key":"10.1016\/j.anai.2025.10.026_bib0589","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","article-title":"A homozygous CARD9 mutation in a family with susceptibility to fungal infections","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0590","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-9610(99)80167-6","article-title":"The surgical implications of chronic granulomatous disease","volume":"169","author":"Eckert","year":"1995","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0591","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s10875-013-9890-5","article-title":"Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome","volume":"33","author":"Freeman","year":"2013","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0592","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaip.2019.01.016","article-title":"Antibiotic prophylaxis for dental treatment in patients with immunodeficiency","volume":"7","author":"Squire","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0593","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamainternmed.2014.5841","article-title":"Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis","volume":"175","author":"Viswanathan","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0594","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/520985","article-title":"Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease","volume":"45","author":"Siddiqui","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5 Pt 2","key":"10.1016\/j.anai.2025.10.026_bib0595","doi-asserted-by":"crossref","first-page":"32r","DOI":"10.1203\/PDR.0b013e31819dc8c5","article-title":"Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes","volume":"65","author":"Freeman","year":"2009","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0596","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/432120","article-title":"Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency","volume":"41","author":"Zerbe","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0597","doi-asserted-by":"crossref","DOI":"10.1099\/jmmcr.0.005084","article-title":"Chromobacterium violaceum infection in chronic granulomatous disease: a case report and review of the literature","volume":"4","author":"Meher-Homji","year":"2017","journal-title":"JMM Case Rep"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0598","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/j.jaip.2020.06.021","article-title":"Cryptosporidium infection in dedicator of cytokinesis 8 (DOCK 8) deficiency","volume":"8","author":"Ben Yakov","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0599","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2016.07.039","article-title":"Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation","volume":"139","author":"de la Morena","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0600","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s10875-021-01031-5","article-title":"Genomic spectrum and phenotypic heterogeneity of human IL-21 receptor deficiency","volume":"41","author":"Cagdas","year":"2021","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0601","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anai.2025.10.026_bib0602","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rmed.2016.04.007","article-title":"Lung transplantation for non-cystic fibrosis bronchiectasis","volume":"115","author":"Rademacher","year":"2016","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0603","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/lt.24979","article-title":"Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome","volume":"24","author":"Azzu","year":"2018","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0604","doi-asserted-by":"crossref","first-page":"66","DOI":"10.6002\/ect.2022.0067","article-title":"Good long-term outcome following liver transplant in a patient with common variable immunodeficiency syndrome despite multiple infections and recurrent nodular regenerative hyperplasia","volume":"21","author":"Bonatti","year":"2023","journal-title":"Exp Clin Transplant"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0605","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaci.2016.11.050","article-title":"IgG trough levels and progression of pulmonary disease in pediatric and adult common variable immunodeficiency disorder patients","volume":"140","author":"Janssen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0606","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2022.12.813","article-title":"The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease","volume":"152","author":"Smits","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0607","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2020.07.021","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"147","author":"Verbsky","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0608","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/all.13753","article-title":"Lung disease in STAT3 hyper-IgE syndrome requires intense therapy","volume":"74","author":"Kr\u00f6ner","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2025.10.026_bib0609","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.606099","article-title":"Treatment strategies for GLILD in common variable immunodeficiency: A systematic review","volume":"12","author":"Lamers","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0610","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-018-8689-9","article-title":"Gastrointestinal disorders associated with primary immunodeficiency diseases","volume":"57","author":"Hartono","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0611","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10875-013-9892-3","article-title":"The role of HLA DQ2 and DQ8 in dissecting celiac-like disease in common variable immunodeficiency","volume":"33","author":"Venhoff","year":"2013","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0612","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0613","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10875-023-01604-6","article-title":"CVID-associated intestinal disorders in the USIDNET registry: an analysis of disease manifestations, functional status, comorbidities, and treatment","volume":"44","author":"Franzblau","year":"2023","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0614","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/infdis\/jiac085","article-title":"Clinical and in vitro evidence favoring immunoglobulin treatment of a chronic Norovirus infection in a patient with common variable immunodeficiency","volume":"226","author":"van Kampen","year":"2022","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0615","doi-asserted-by":"crossref","first-page":"e1926","DOI":"10.1002\/rmv.1926","article-title":"Norovirus infection in primary immune deficiency","volume":"27","author":"Brown","year":"2017","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0616","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cgh.2021.03.039","article-title":"Safety and efficacy of ustekinumab in the inflammatory bowel disease of chronic granulomatous disease","volume":"20","author":"Bhattacharya","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0617","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/657308","article-title":"Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis","volume":"51","author":"Uzel","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0618","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-020-00901-8","article-title":"Infections in patients with chronic granulomatous disease treated with tumor necrosis factor alpha blockers for inflammatory complications","volume":"41","author":"Conrad","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0619","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.707369","article-title":"Candida glabrata lymphadenitis following infliximab therapy for inflammatory bowel disease in a patient with chronic granulomatous disease: case report and literature review","volume":"9","author":"Lehman","year":"2021","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0620","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10875-019-00659-8","article-title":"Chronic granulomatous disease-associated IBID resolves and does not adversely impact survival following allogeneic HCT","volume":"39","author":"Marsh","year":"2019","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0621","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/cid\/cir896","article-title":"Corticosteroid therapy for liver abscess in chronic granulomatous disease","volume":"54","author":"Leiding","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0622","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/jpsu.2003.50189","article-title":"Cut it out: managing hepatic abscesses in patients with chronic granulomatous disease","volume":"38","author":"Chen","year":"2003","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0623","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaci.2021.05.028","article-title":"Nodular regenerative hyperplasia in X-linked agammaglobulinemia: an underestimated and severe complication","volume":"149","author":"Nunes-Santos","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0624","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency","volume":"33","author":"Fuss","year":"2013","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0625","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/hep.32539","article-title":"Tip of the iceberg: A comprehensive review of liver disease in Inborn errors of immunity","volume":"76","author":"Sharma","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.anai.2025.10.026_bib0626","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108779","article-title":"Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency","volume":"229","author":"Lanz","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0627","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.796065","article-title":"Rubella virus infected macrophages and neutrophils define patterns of granulomatous inflammation in inborn and acquired errors of immunity","volume":"12","author":"Perelygina","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0628","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaci.2006.01.034","article-title":"Etanercept treatment of cutaneous granulomas in common variable immunodeficiency","volume":"117","author":"Lin","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0629","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations","volume":"132","author":"Chu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0630","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.anai.2022.03.024","article-title":"Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE","volume":"128","author":"Bakaa","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0631","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/pde.15072","article-title":"Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab","volume":"39","author":"Nihal","year":"2022","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0632","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood.2023022658","article-title":"A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome","volume":"144","author":"Badolato","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0633","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1469-8749.2007.00210.x","article-title":"Motor development in school-aged children with 22q11 deletion (velocardiofacial\/DiGeorge syndrome)","volume":"49","author":"Van Aken","year":"2007","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0634","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1096-8628(19990716)85:2<127::AID-AJMG6>3.0.CO;2-F","article-title":"Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion","volume":"85","author":"Gerdes","year":"1999","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0635","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S1097-2765(01)00408-7","article-title":"DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency","volume":"8","author":"O'Driscoll","year":"2001","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0636","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13023-020-01516-3","article-title":"Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential","volume":"15","author":"Meixner","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0637","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/acr.24805","article-title":"Inflammatory arthritis and the effect of physical activity on quality of life and self-reported function: A systematic review and meta-analysis","volume":"74","author":"Bj\u00f6rk","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0638","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/BOR.0000000000000696","article-title":"Benefits and promotion of physical activity in rheumatoid arthritis","volume":"32","author":"Katz","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0639","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/03009742.2014.995699","article-title":"X-linked agammaglobulinemia in two siblings with a novel mutation in the BTK gene who presented with polyarticular juvenile idiopathic arthritis","volume":"44","author":"Patiroglu","year":"2015","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0640","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/ard.2004.030049","article-title":"X linked agammaglobulinaemia and rheumatoid arthritis","volume":"64","author":"Verbruggen","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0641","doi-asserted-by":"crossref","first-page":"40","DOI":"10.55563\/clinexprheumatol\/bbuvih","article-title":"Association of common variable immunodeficiency and rare and complex connective tissue and musculoskeletal diseases. A systematic literature review","volume":"40","author":"Mucke","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0642","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2249.2007.03321.x","article-title":"Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology","volume":"148","author":"Cale","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0643","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jaci.2020.07.024","article-title":"Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome","volume":"147","author":"Goel","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0644","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1542\/peds.2009-2987","article-title":"Occurrence of aortic aneurysms in 5 cases of Wiskott-Aldrich syndrome","volume":"127","author":"Pellier","year":"2011","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0645","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/rheumatology\/kez311","article-title":"The therapeutic efficacy of intravenous immunoglobulin in anti-neutrophilic cytoplasmic antibody-associated vasculitis: a meta-analysis","volume":"59","author":"Shimizu","year":"2020","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0646","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anai.2025.10.026_bib0647","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fimmu.2019.00777","article-title":"A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients with Primary Immunodeficiencies and Immune dysregulatory Disorders (Inborn Errors of Immunity)","volume":"10","author":"Riaz","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0648","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3389\/fimmu.2018.02912","article-title":"Current understanding and future research priorities in malignancy associated with inborn errors of immunity and DNA repair disorders: the perspective of an interdisciplinary working group","volume":"9","author":"Bomken","year":"2018","journal-title":"Front Immunol"},{"issue":"19","key":"10.1016\/j.anai.2025.10.026_bib0649","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.2023.12914","article-title":"Red blood cell transfusion: 2023 AABB international guidelines","volume":"330","author":"Carson","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0650","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bjh.17015","article-title":"Guidelines on the use of irradiated blood components","volume":"191","author":"Foukaneli","year":"2020","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0651","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","article-title":"Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients","volume":"155","author":"Gobert","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0652","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2141.2007.06616.x","article-title":"Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency","volume":"138","author":"Kim","year":"2007","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0653","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaip.2019.07.032","article-title":"Rituximab unveils hypogammaglobulinemia and immunodeficiency in children with autoimmune cytopenia","volume":"8","author":"Ottaviano","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0654","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jaci.2021.03.041","article-title":"Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients","volume":"148","author":"Labrosse","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0655","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cei.12039","article-title":"Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients","volume":"172","author":"Wong","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"14","key":"10.1016\/j.anai.2025.10.026_bib0656","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2015-03-634493","article-title":"Severe chronic primary neutropenia in adults: report on a series of 108 patients","volume":"126","author":"Sicre de Fontbrune","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0657","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOH.0000000000000208","article-title":"How I diagnose and treat neutropenia","volume":"23","author":"Dale","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0658","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00277-006-0202-5","article-title":"Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology","volume":"86","author":"Dungarwalla","year":"2007","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0659","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MPH.0000000000001005","article-title":"Ataxia telangiectasia and cancer predisposition: challenges in management","volume":"40","author":"Upadhyaya","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0660","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12969-019-0309-6","article-title":"Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome","volume":"17","author":"Halyabar","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0661","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/MPH.0000000000002602","article-title":"Pediatric hemophagocytic lymphohistiocytosis: formation of an interdisciplinary HLH working group at a single institution","volume":"45","author":"Watts","year":"2023","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0662","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaip.2020.01.038","article-title":"Primary immunodeficiency diseases and Bacillus Calmette-Gu\u00e9rin (BCG)-vaccine-derived complications: A systematic review","volume":"8","author":"Fekrvand","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"31","key":"10.1016\/j.anai.2025.10.026_bib0663","doi-asserted-by":"crossref","first-page":"847","DOI":"10.15585\/mmwr.mm7231a3","article-title":"Notes from the field: measles outbreak - Central Ohio, 2022-2023","volume":"72","author":"Tiller","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"suppl 4","key":"10.1016\/j.anai.2025.10.026_bib0664","doi-asserted-by":"crossref","first-page":"S392","DOI":"10.1093\/infdis\/jiac221","article-title":"Monitoring varicella vaccine impact on varicella incidence in the United States: surveillance challenges and changing epidemiology, 1995-2019","volume":"226","author":"Marin","year":"2022","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0665","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1093\/cid\/ciaa150","article-title":"Continued evidence of the impact of rotavirus vaccine in children less than 3 years of age from the United States new vaccine surveillance network: a multisite active surveillance program, 2006-2016","volume":"71","author":"Staat","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anai.2025.10.026_bib0666","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101732","article-title":"Human thymus in health and disease: recent advances in diagnosis and biology","volume":"66","author":"Bosticardo","year":"2023","journal-title":"Semin Immunol"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.10.026_bib0667","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/infdis\/jiad145","article-title":"SARS-CoV-2 infection and response to COVID-19 vaccination in patients with primary immunodeficiencies","volume":"228","author":"Paris","year":"2023","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0668","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0669","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1099\/0022-1317-80-2-399","article-title":"Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome","volume":"80","author":"de Gruijl","year":"1999","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0670","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/cid\/ciy874","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaA","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"32","key":"10.1016\/j.anai.2025.10.026_bib0671","doi-asserted-by":"crossref","first-page":"696","DOI":"10.15585\/mmwr.mm7332e1","article-title":"Use of respiratory syncytial virus vaccines in adults aged \u226560 years: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2024","volume":"73","author":"Britton","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"41","key":"10.1016\/j.anai.2025.10.026_bib0672","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","volume":"72","author":"Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"10.1016\/j.anai.2025.10.026_bib0673","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: Recommendations of the Advisory Committee on Immunization Practices - United States","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0674","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009","volume":"208","author":"Weinmann","year":"2013","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0675","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7774\/cevr.2019.8.2.116","article-title":"A clinico-epidemiological multicenter study of herpes zoster in immunocompetent and immunocompromised hospitalized children","volume":"8","author":"Hwang","year":"2019","journal-title":"Clin Exp Vaccin Res"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0676","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217749","article-title":"Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: varicella outcomes and safety results from a large, open-label, expanded-access program","volume":"14","author":"Levin","year":"2019","journal-title":"PLOS One"},{"issue":"3A","key":"10.1016\/j.anai.2025.10.026_bib0677","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0002-9343(84)90330-9","article-title":"Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin","volume":"76","author":"Paryani","year":"1984","journal-title":"Am J Med"},{"issue":"21","key":"10.1016\/j.anai.2025.10.026_bib0678","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.vaccine.2016.03.091","article-title":"Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency","volume":"34","author":"Hanitsch","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0679","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.jaci.2018.08.010","article-title":"Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies","volume":"142","author":"Marsh","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0680","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0681","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fped.2019.00434","article-title":"Conditioning perspectives for primary immunodeficiency stem cell transplants","volume":"7","author":"Shaw","year":"2019","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0682","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.jaci.2021.10.017","article-title":"Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006-2014 European cohort","volume":"149","author":"Lankester","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0683","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.anai.2025.10.026_bib0684","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.608653","article-title":"Immune reconstitution after gene therapy approaches in patients with X-linked severe combined immunodeficiency disease","volume":"11","author":"Blanco","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0685","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2017.03.020","article-title":"Thymus transplantation for complete DiGeorge syndrome: European experience","volume":"140","author":"Davies","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0686","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.721917","article-title":"Case report: unmanipulated matched sibling donor hematopoietic cell transplantation in TBX1 congenital athymia: A lifesaving therapeutic approach when facing a systemic viral infection","volume":"12","author":"Chitty-Lopez","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0687","doi-asserted-by":"crossref","first-page":"e30809","DOI":"10.1002\/pbc.30809","article-title":"Non-conditioned cord blood transplantation for infection control in athymic CHARGE syndrome","volume":"71","author":"Sonoda","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0688","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jaci.2007.08.048","article-title":"Long-term results of bone marrow transplantation in complete DiGeorge syndrome","volume":"120","author":"Land","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0689","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/1744666X.2021.1901582","article-title":"Germline IKZF1 mutations and their impact on immunity: IKAROS-associated diseases and pathophysiology","volume":"17","author":"Kuehn","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0690","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2019.03.025","article-title":"Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1\/IKAROS mutations","volume":"144","author":"Kellner","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0691","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108801","article-title":"Stem cell transplantation as treatment for major histocompatibility class I deficiency","volume":"229","author":"Tsilifis","year":"2021","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0692","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jaci.2018.12.1010","article-title":"Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT\/ESID-IEWP-SCETIDE-PIDTC study","volume":"143","author":"Ferrua","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0693","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaip.2018.10.035","article-title":"Hematopoietic stem cell transplantation as treatment for patients with DOCK8 deficiency","volume":"7","author":"Aydin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.10.026_bib0694","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fped.2019.00516","article-title":"Hematopoietic cell transplantation for MHC Class II deficiency","volume":"7","author":"Lum","year":"2019","journal-title":"Front Pediatr"},{"issue":"23","key":"10.1016\/j.anai.2025.10.026_bib0695","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood.2019002939","article-title":"Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report","volume":"135","author":"Burroughs","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0696","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood-2017-03-771600","article-title":"Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG\/NEMO mutations","volume":"130","author":"Miot","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0697","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s10875-022-01332-3","article-title":"Reduced intensity conditioning allogeneic transplant for SCID associated with cartilage hair hypoplasia","volume":"42","author":"Fitch","year":"2022","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0698","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.hoc.2025.02.002","article-title":"Genetics of familial hemophagocytic lymphohistiocytosis","volume":"39","author":"Zhang","year":"2025","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0699","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jaci.2014.08.039","article-title":"Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding","volume":"135","author":"Cetica","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0700","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/pbc.24637","article-title":"Clinical characteristics and outcomes of Ch\u00e9diak-Higashi syndrome: a nationwide survey of Japan","volume":"60","author":"Nagai","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"15","key":"10.1016\/j.anai.2025.10.026_bib0701","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2012-10-463166","article-title":"The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2","volume":"121","author":"Jessen","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0702","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","article-title":"X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease","volume":"117","author":"Booth","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.anai.2025.10.026_bib0703","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.660520","article-title":"Evolution of our understanding of XIAP deficiency","volume":"9","author":"Mudde","year":"2021","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0704","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10875-021-01103-6","article-title":"Reduced-intensity\/reduced-toxicity conditioning approaches are tolerated in XIAP deficiency but patients fare poorly with acute GVHD","volume":"42","author":"Arnold","year":"2022","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0705","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/bloodadvances.2018027417","article-title":"Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation","volume":"3","author":"Li","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0706","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10875-020-00814-6","article-title":"Neuroinflammatory disease as an isolated manifestation of hemophagocytic lymphohistiocytosis","volume":"40","author":"Blincoe","year":"2020","journal-title":"J Clin Immunol"},{"issue":"19","key":"10.1016\/j.anai.2025.10.026_bib0707","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1182\/blood-2018-01-827485","article-title":"Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis","volume":"132","author":"Lucchini","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.anai.2025.10.026_bib0708","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108993","article-title":"Preemptive hematopoietic cell transplantation for asymptomatic patients with X-linked lymphoproliferative syndrome type 1","volume":"237","author":"Tomomasa","year":"2022","journal-title":"Clin Immunol"},{"issue":"26","key":"10.1016\/j.anai.2025.10.026_bib0709","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","article-title":"Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0710","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2021.07.031","article-title":"Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders","volume":"149","author":"Marsh","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0711","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/bloodadvances.2020001748","article-title":"Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis","volume":"4","author":"Felber","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0712","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2012.09.025","article-title":"Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation","volume":"131","author":"Engelhardt","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0713","article-title":"Early diagnosis and hematopoietic stem cell transplantation for IL10R deficiency leading to very early-onset inflammatory bowel disease are essential in familial cases","volume":"2016","author":"Karaca","year":"2016","journal-title":"Case Rep Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0714","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103442","article-title":"Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation","volume":"22","author":"Paskiewicz","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0716","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10875-021-01098-0","article-title":"Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients","volume":"41","author":"Hashem","year":"2021","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0717","first-page":"262","article-title":"Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III","volume":"5","author":"Bakhtiar","year":"2021","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0718","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.2020005590","article-title":"Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults","volume":"136","author":"Chiesa","year":"2020","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.anai.2025.10.026_bib0719","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1182\/blood.2022019586","article-title":"Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD","volume":"142","author":"Leiding","year":"2023","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0720","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3324\/haematol.2019.216101","article-title":"Role of interferon-\u03b3 in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"Merli","year":"2019","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0721","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10875-020-00855-x","article-title":"Successful hematopoietic stem cell transplantation in a patient with complete IFN-\u03b3 Receptor 2 deficiency: a case report and literature review","volume":"40","author":"Tovo","year":"2020","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0722","first-page":"881.e1","article-title":"Hematopoietic stem cell transplantation for patients with autosomal recessive complete INF-\u03bb Receptor 2 deficiency: experience in Oman","volume":"27","author":"Nazir","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0723","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","article-title":"Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations","volume":"141","author":"Leiding","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0724","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaci.2023.05.016","article-title":"Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations","volume":"152","author":"Kunvarjee","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0725","first-page":"45","article-title":"Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group","volume":"90","author":"Donadieu","year":"2005","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0726","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/bloodadvances.2021005539","article-title":"Hematologic complications with age in Shwachman-Diamond syndrome","volume":"6","author":"Furutani","year":"2022","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0727","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41409-020-0863-z","volume":"55","author":"Cesaro","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0728","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.bbmt.2020.04.029","article-title":"Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome","volume":"26","author":"Myers","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0729","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2352-3026(19)30206-6","article-title":"Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study","volume":"7","author":"Myers","year":"2020","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0730","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2018.01.030","article-title":"Allogeneic hematopoietic stem cell transplantation for GATA2 deficiency using a busulfan-based regimen","volume":"24","author":"Parta","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0731","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/s41409-021-01374-y","article-title":"Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome","volume":"56","author":"Bortnick","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0732","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbmt.2011.11.014","article-title":"NHLBI\/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors","volume":"18","author":"Bunin","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0733","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbmt.2017.04.026","volume":"23","author":"Heimall","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0734","first-page":"317","article-title":"An immune recovery-based revaccination protocol for pediatric hematopoietic stem cell transplant recipients: revaccination outcomes following pediatric HSCT","volume":"27","author":"Haynes","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0735","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0736","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s10875-021-01044-0","article-title":"Care of children with DiGeorge before and after cultured Thymus Tissue implantation","volume":"41","author":"Gupton","year":"2021","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0737","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/bmt.2012.5","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"47","author":"Majhail","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0738","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaci.2023.09.027","article-title":"Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study","volume":"153","author":"Eissa","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0739","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.bbmt.2012.03.003","article-title":"Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism","volume":"18","author":"Eapen","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0740","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10875-022-01257-x","article-title":"Impact of JAK inhibitors in pediatric patients with STAT1 gain of function (GOF) Mutations-10 children and review of the literature","volume":"42","author":"Dey\u00e0-Mart\u00ednez","year":"2022","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0741","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10875-020-00943-y","article-title":"Stepwise reversal of immune dysregulation due to STAT1 gain-of-function mutation following Ruxolitinib bridge therapy and transplantation","volume":"41","author":"Kayaoglu","year":"2021","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0742","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12185-020-02860-7","article-title":"Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation","volume":"112","author":"Moriya","year":"2020","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0743","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaci.2018.02.045","article-title":"Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)","volume":"142","author":"Meesilpavikkai","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0744","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s10875-021-00975-y","article-title":"Clinical and immunological heterogeneity in Japanese patients with gain-of-function variants in STAT3","volume":"41","author":"Tanita","year":"2021","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0745","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10875-020-00914-3","article-title":"Life-saving, dose-adjusted, targeted therapy in a patient with a STAT3 gain-of-function mutation","volume":"41","author":"Sarfati","year":"2021","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0746","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/rccm.201906-1204LE","article-title":"Successful treatment of interstitial lung disease in STAT3 gain-of-function using JAK inhibitors","volume":"202","author":"Silva-Carmona","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0747","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s10875-022-01346-x","article-title":"SOCS1 haploinsufficiency presenting as severe enthesitis, bone marrow hypocellularity, and refractory thrombocytopenia in a pediatric patient with subsequent response to JAK inhibition","volume":"42","author":"Michniacki","year":"2022","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0748","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaip.2020.11.050","article-title":"JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease","volume":"9","author":"Eisenberg","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"24","key":"10.1016\/j.anai.2025.10.026_bib0749","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa2202318","article-title":"Variant STAT4 and response to Ruxolitinib in an autoinflammatory syndrome","volume":"388","author":"Baghdassarian","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0750","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","article-title":"Efficacy of the Janus kinase 1\/2 inhibitor Ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children","volume":"138","author":"Fr\u00e9mond","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0751","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1056\/NEJMc2001362","article-title":"Janus kinase inhibition in the Aicardi-Gouti\u00e8res syndrome","volume":"383","author":"Vanderver","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0752","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/art.40805","article-title":"Efficacy of baricitinib in the treatment of chilblains associated with Aicardi-Gouti\u00e8res syndrome, a Type I interferonopathy","volume":"71","author":"Meesilpavikkai","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0753","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/annrheumdis-2021-221814","article-title":"The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI and AGS","volume":"81","author":"Cetin Gedik","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0754","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/pde.14517","article-title":"Successful treatment of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome with tofacitinib","volume":"38","author":"Patel","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0755","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0756","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/pbc.25575","article-title":"A phase 1 dosing study of Ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: a Children's Oncology Group phase 1 consortium study (ADVL1011)","volume":"62","author":"Loh","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0757","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bjd.18898","article-title":"Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials","volume":"183","author":"Simpson","year":"2020","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0758","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10875-022-01426-y","article-title":"Pegylated recombinant adenosine deaminase maintains detoxification and lymphocyte counts in patients with ADA-SCID","volume":"43","author":"Dorsey","year":"2023","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0759","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jaip.2023.01.028","article-title":"Long-term immune reconstitution in ADA-deficient patients treated with Elapegademase: A real-world experience","volume":"11","author":"Murguia-Favela","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0760","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10875-024-01710-z","article-title":"Treatment with Elapegademase restores immunity in infants with adenosine deaminase deficient severe combined immunodeficiency","volume":"44","author":"Hicks","year":"2024","journal-title":"J Clin Immunol"},{"issue":"6246","key":"10.1016\/j.anai.2025.10.026_bib0761","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0762","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jaci.2023.08.004","article-title":"Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency","volume":"152","author":"Taghizade","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0763","article-title":"Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier","volume":"16","author":"Sj\u00f6str\u00f6m","year":"2021","journal-title":"Brain Behav Immun Health"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0764","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/annrheumdis-2021-221801","volume":"81","author":"Romano","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0765","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/kev416","article-title":"Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome","volume":"55","author":"Kuemmerle-Deschner","year":"2016","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0766","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"20","key":"10.1016\/j.anai.2025.10.026_bib0767","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0768","doi-asserted-by":"crossref","first-page":"51","DOI":"10.55563\/clinexprheumatol\/e92f7o","article-title":"Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial","volume":"39","author":"Lachmann","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0769","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2020-217419","article-title":"Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial","volume":"79","author":"Ozen","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0770","doi-asserted-by":"crossref","first-page":"30","DOI":"10.55563\/clinexprheumatol\/815tdt","article-title":"Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients","volume":"39","author":"Atas","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0771","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0772","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/rheumatology\/keab696","article-title":"Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial","volume":"61","author":"Jeyaratnam","year":"2022","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0773","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0774","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/rheumatology\/kew031","article-title":"Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome","volume":"55","author":"Omenetti","year":"2016","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0775","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.41624","article-title":"Novel Majeed syndrome-causing LPIN2 mutations link bone inflammation to inflammatory M2 macrophages and accelerated osteoclastogenesis","volume":"73","author":"Bhuyan","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0776","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/annrheumdis-2012-201818","article-title":"Efficacy of anti-IL-1 treatment in Majeed syndrome","volume":"72","author":"Herlin","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0777","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/rheumatology\/kez317","article-title":"Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra","volume":"59","author":"Roy","year":"2020","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0778","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.30170","article-title":"Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation","volume":"63","author":"Borghini","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0779","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12969-022-00669-8","article-title":"NLRP-associated systemic autoinflammatory diseases in children","volume":"20","author":"Wang","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0780","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4 causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J Exp Med"},{"issue":"19","key":"10.1016\/j.anai.2025.10.026_bib0781","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.3390\/jcm10194369","article-title":"NLRC4 GOF mutations, a challenging diagnosis from neonatal age to adulthood","volume":"10","author":"Bardet","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0782","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jaci.2019.06.017","article-title":"Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1\u03b2 inhibition","volume":"144","author":"Gernez","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.10.026_bib0783","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.clinthera.2012.09.009","article-title":"Long-term efficacy and safety profile of Rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study","volume":"34","author":"Hoffman","year":"2012","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.anai.2025.10.026_bib0784","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1182\/blood-2006-09-045427","article-title":"G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms","volume":"109","author":"Donini","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0785","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bjh.18840","article-title":"HAX1-related congenital neutropenia: long-term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR)","volume":"202","author":"Pogozhykh","year":"2023","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0786","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jpeds.2011.09.019","article-title":"Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia","volume":"160","author":"Boztug","year":"2012","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0787","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1203\/00006450-199401000-00017","volume":"35","author":"McCawley","year":"1994","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0788","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MOH.0000000000000472","article-title":"Neutropenia in Barth syndrome: characteristics, risks, and management","volume":"26","author":"Steward","year":"2019","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0789","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00043426-200406000-00009","article-title":"Granulocyte colony-stimulating factor-responsive chronic neutropenia in cartilage-hair hypoplasia","volume":"26","author":"Ammann","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"23","key":"10.1016\/j.anai.2025.10.026_bib0790","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1073\/pnas.86.23.9499","article-title":"The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo","volume":"86","author":"Lord","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0791","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.10255","article-title":"Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic neutropenia International Registry","volume":"72","author":"Dale","year":"2003","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0792","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/imr.12719","article-title":"WHIM syndrome: immunopathogenesis, treatment and cure strategies","volume":"287","author":"McDermott","year":"2019","journal-title":"Immunol Rev"},{"issue":"15","key":"10.1016\/j.anai.2025.10.026_bib0793","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2013-09-527226","article-title":"A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor","volume":"123","author":"McDermott","year":"2014","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.anai.2025.10.026_bib0794","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164918","article-title":"A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome","volume":"133","author":"McDermott","year":"2023","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0795","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10545-013-9664-5","article-title":"Update on transcobalamin deficiency: clinical presentation, treatment and outcome","volume":"37","author":"Trakadis","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0796","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41435-022-00191-7","article-title":"Immunodeficiency associated with a novel functionally defective variant of SLC19A1 benefits from folinic acid treatment","volume":"24","author":"G\u00f6k","year":"2023","journal-title":"Genes Immun"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0797","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clim.2014.03.014","article-title":"Impact of folate therapy on combined immunodeficiency secondary to hereditary folate malabsorption","volume":"153","author":"Kishimoto","year":"2014","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0798","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","article-title":"Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency","volume":"40","author":"Huemer","year":"2017","journal-title":"J Inherit Metab Dis"},{"issue":"6-7","key":"10.1016\/j.anai.2025.10.026_bib0799","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00439-020-02126-6","article-title":"The monogenic basis of human tuberculosis","volume":"139","author":"Boisson-Dupuis","year":"2020","journal-title":"Hum Genet"},{"issue":"19","key":"10.1016\/j.anai.2025.10.026_bib0800","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1056\/NEJM199405123301904","article-title":"Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report","volume":"330","author":"Holland","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0801","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.102468","article-title":"Successful treatment of invasive mycobacterium infection with interferon beta in a patient with interferon-gamma Receptor 1 deficiency","volume":"17","author":"Alroqi","year":"2024","journal-title":"J Infect Public Health"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0802","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00431-004-1599-2","article-title":"Variable outcome of experimental interferon-gamma therapy of disseminated bacillus Calmette-Guerin infection in two unrelated interleukin-12Rbeta1-deficient Slovakian children","volume":"164","author":"Ulrichs","year":"2005","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.anai.2025.10.026_bib0803","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10875-024-01661-5","article-title":"Recombinant IFN-\u03b31b treatment in a patient with inherited IFN-\u03b3 deficiency","volume":"44","author":"Rosain","year":"2024","journal-title":"J Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0804","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1182\/blood.V94.12.3976","article-title":"Correction of leukocyte adhesion deficiency type II with oral fucose","volume":"94","author":"Marquardt","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0805","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood.V97.1.330","article-title":"Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts","volume":"97","author":"L\u00fchn","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0806","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/ajmg.a.62737","article-title":"Defining the mild variant of leukocyte adhesion deficiency type II (SLC35C1-congenital disorder of glycosylation) and response to l-fucose therapy: insights from two new families and review of the literature","volume":"188","author":"Tahata","year":"2022","journal-title":"Am J Med Genet A"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0807","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2022018546","article-title":"A randomized, placebo-controlled phase 3 trial of the PI3K\u03b4 inhibitor leniolisib for activated PI3K\u03b4 syndrome","volume":"141","author":"Rao","year":"2023","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.anai.2025.10.026_bib0808","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1182\/bloodadvances.2023011000","article-title":"Long-term treatment with selective PI3K\u03b4 inhibitor leniolisib in adults with activated PI3K\u03b4 syndrome","volume":"8","author":"Rao","year":"2024","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0809","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/422993","article-title":"Long-term interferon-gamma therapy for patients with chronic granulomatous disease","volume":"39","author":"Marciano","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0810","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.jaci.2016.11.029","article-title":"Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16)","volume":"139","author":"Ballow","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0811","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2016.07.012","article-title":"Development and initial validation of a questionnaire to measure health-related quality of life of adults with common variable immune deficiency: the CVID_QoL questionnaire","volume":"4","author":"Quinti","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.10.026_bib0812","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13223-015-0092-y","article-title":"Health-related quality of life in patients with primary immunodeficiency disease","volume":"11","author":"Jiang","year":"2015","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0813","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jaip.2019.02.013","article-title":"Health-related quality of life in children and adults with primary immunodeficiencies: A systematic review and meta-analysis","volume":"7","author":"Peshko","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0814","first-page":"504","article-title":"Home-based immunoglobulin infusion therapy: quality of life and patient health perceptions","volume":"67","author":"Daly","year":"1991","journal-title":"Ann Allergy"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0815","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2007.06.009","article-title":"Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy","volume":"126","author":"Gardulf","year":"2008","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0816","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10875-006-8905-x","article-title":"Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home","volume":"26","author":"Nicolay","year":"2006","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0817","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10875-012-9758-0","article-title":"Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant","volume":"33","author":"Cole","year":"2013","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0818","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10875-017-0404-8","article-title":"Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment","volume":"37","author":"Rider","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0819","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpn.2022.07.004","article-title":"Quality of life and neurological disability in children and young people with ataxia telangiectasia","volume":"40","author":"McGlashan","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0820","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10875-022-01222-8","article-title":"Health-related quality of life in 91 patients with X-linked agammaglobulinemia","volume":"42","author":"Altman","year":"2022","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.10.026_bib0821","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/apa.15752","article-title":"Primary antibody deficiency: the impact on the quality of life and mental health of affected children and their parents","volume":"110","author":"Berg","year":"2021","journal-title":"Acta Paediatr"},{"issue":"7","key":"10.1016\/j.anai.2025.10.026_bib0822","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10875-022-01286-6","article-title":"Quality of life and social and psychological outcomes in adulthood following allogeneic HSCT in childhood for inborn errors of immunity","volume":"42","author":"Nicholson","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2025.10.026_bib0823","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.984110","article-title":"Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese","volume":"13","author":"Kan","year":"2022","journal-title":"Front Immunol"},{"issue":"15","key":"10.1016\/j.anai.2025.10.026_bib0824","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood-2016-11-748616","article-title":"Long-term outcome of hematopoietic stem cell transplantation for IL2RG\/JAK3 SCID: a cohort report","volume":"129","author":"Abd Hamid","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0825","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4065\/84.1.16","article-title":"Incidence and temporal trends of primary immunodeficiency: a population-based cohort study","volume":"84","author":"Joshi","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0826","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10875-024-01781-y","article-title":"A cross-sectional study of health-related quality of life in patients with predominantly antibody deficiency","volume":"44","author":"Elmoursi","year":"2024","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0827","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036250","article-title":"Investigating self-perceived health and quality of life: a longitudinal prospective study among beginner recreational exercisers in a fitness club setting","volume":"10","author":"Heiestad","year":"2020","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.anai.2025.10.026_bib0828","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003741","article-title":"Participant-reported health status predicts cardiovascular and all-cause mortality independent of established and nontraditional biomarkers: evidence from a representative US sample","volume":"5","author":"Barger","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.anai.2025.10.026_bib0829","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s10875-023-01474-y","article-title":"Perceived sleep quality in individuals with inborn errors of immunity","volume":"43","author":"Sowers","year":"2023","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0830","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13223-022-00746-3","article-title":"Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes","volume":"18","author":"Mallick","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2025.10.026_bib0831","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/jpc.13560","article-title":"Haematopoietic stem cell transplantation for severe combined immunodeficiency: long-term health outcomes and patient perspectives","volume":"53","author":"Lee","year":"2017","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.anai.2025.10.026_bib0832","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s10875-020-00775-w","article-title":"Health-related quality of life and multidimensional fatigue scale in children with primary immunodeficiencies","volume":"40","author":"Ridao-Manonellas","year":"2020","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0833","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13023-021-01918-x","article-title":"Which triggers could support timely identification of primary antibody deficiency? A qualitative study using the patient perspective","volume":"16","author":"Janssen","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0834","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10875-017-0472-9","article-title":"Exercise perception and behaviors in individuals living with primary immunodeficiency disease","volume":"38","author":"Sowers","year":"2018","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.10.026_bib0835","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12865-020-00371-y","article-title":"Subcutaneous immunoglobulin in primary immunodeficiency - impact of training and infusion characteristics on patient-reported outcomes","volume":"21","author":"Mallick","year":"2020","journal-title":"BMC Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0836","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaip.2020.10.028","article-title":"Abatacept use is associated with steroid dose reduction and improvement in fatigue and CD4-dysregulation in CVID patients with interstitial lung disease","volume":"9","author":"von Spee-Mayer","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2025.10.026_bib0837","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10875-019-0592-5","article-title":"Health-related quality of life in patients with CVID under different schedules of immunoglobulin administration: prospective multicenter study","volume":"39","author":"Pulvirenti","year":"2019","journal-title":"J Clin Immunol"}],"updated-by":[{"DOI":"10.1016\/j.anai.2026.08.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000}},{"DOI":"10.1016\/j.anai.2026.08.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:45:51Z","timestamp":1779345951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625013006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":837,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1081120625013006"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.10.026","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2025 Inborn errors of immunity practice parameter","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}